|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00149596
|
|
|
SLE
|
[NCBI]
|
0.000799471
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000765921
|
|
|
zinc, elevated plasma
|
[NCBI]
|
0.000765921
|
|
|
ETM2
|
[NCBI]
|
0.000653591
|
|
|
anosmia, congenital
|
[NCBI]
|
0.000653591
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000615577
|
|
|
inclusion body myositis
|
[NCBI]
|
0.000584051
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000584051
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000584051
|
|
|
SHFM2
|
[NCBI]
|
0.000584051
|
|
|
AUTS9
|
[NCBI]
|
0.000557135
|
|
|
RCD1
|
[NCBI]
|
0.000557135
|
|
|
IBD5
|
[NCBI]
|
0.00049422
|
|
|
scott syndrome
|
[NCBI]
|
0.00046186
|
|
|
DURS1
|
[NCBI]
|
0.00043447
|
|
|
GPS
|
[NCBI]
|
0.00041076
|
|
|
SHFM3
|
[NCBI]
|
0.000400009
|
|
|
HBB
|
[NCBI]
|
0.000360373
|
|
|
EEC1
|
[NCBI]
|
0.000354466
|
|
|
CF
|
[NCBI]
|
0.000333748
|
|
|
TNF
|
[NCBI]
|
0.000308961
|
|
|
HCH
|
[NCBI]
|
0.000305765
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
0.000300716
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000289207
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000283919
|
|
|
SHFM1
|
[NCBI]
|
0.00026438
|
|
|
VEGF
|
[NCBI]
|
0.000262732
|
|
|
FGFR3
|
[NCBI]
|
0.000261575
|
|
|
PEE1
|
[NCBI]
|
0.000259856
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
0.000255411
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000251188
|
|
|
OFC1
|
[NCBI]
|
0.000207673
|
|
|
TTR
|
[NCBI]
|
0.000191275
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
0.000189349
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
0.000184642
|
|
|
autism
|
[NCBI]
|
0.00018201
|
|
|
MFS
|
[NCBI]
|
0.0001809
|
|
|
PRL
|
[NCBI]
|
0.000179227
|
|
|
EGF
|
[NCBI]
|
0.000179031
|
|
|
HBA2
|
[NCBI]
|
0.000177539
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
0.000171973
|
|
|
COMT
|
[NCBI]
|
0.000159445
|
|
|
muenke syndrome
|
[NCBI]
|
0.000156022
|
|
|
NGFB
|
[NCBI]
|
0.000142275
|
|
|
PSEN1
|
[NCBI]
|
0.000138681
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
0.000133473
|
|
|
SW
|
[NCBI]
|
0.000129496
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
0.000129496
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000121471
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
0.000121094
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000120015
|
|
|
ALPS
|
[NCBI]
|
0.000119338
|
|
|
SOD1
|
[NCBI]
|
0.000119122
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
0.000117826
|
|
|
HIDS
|
[NCBI]
|
0.00011418
|
|
|
FGFR2
|
[NCBI]
|
0.000112228
|
|
|
CCK
|
[NCBI]
|
0.000109543
|
|
|
CMD1E
|
[NCBI]
|
0.00010893
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
0.00010893
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
0.00010893
|
|
|
MG
|
[NCBI]
|
0.000106133
|
|
|
MDD
|
[NCBI]
|
0.000105804
|
|
|
PRNP
|
[NCBI]
|
0.000105201
|
|
|
GFAP
|
[NCBI]
|
0.000104474
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000104301
|
|
|
EKV
|
[NCBI]
|
0.000102584
|
|
|
MVK
|
[NCBI]
|
0.0001024
|
|
|
LGMD1C
|
[NCBI]
|
0.000101742
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
0.000101742
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
0.000101742
|
|
|
HOKPP
|
[NCBI]
|
0.000100047
|
|
|
central core disease of muscle
|
[NCBI]
|
9.76301e-05
|
|
|
HBA1
|
[NCBI]
|
9.6889e-05
|
|
|
AVP
|
[NCBI]
|
9.62349e-05
|
|
|
SANDO
|
[NCBI]
|
9.57159e-05
|
|
|
PARK7
|
[NCBI]
|
9.57159e-05
|
|
|
PGL4
|
[NCBI]
|
9.57159e-05
|
|
|
RP10
|
[NCBI]
|
9.57159e-05
|
|
|
MDC1C
|
[NCBI]
|
9.57159e-05
|
|
|
MODY
|
[NCBI]
|
9.51303e-05
|
|
|
MPZ
|
[NCBI]
|
9.23991e-05
|
|
|
DFNB37
|
[NCBI]
|
9.23074e-05
|
|
|
hyaluronidase deficiency
|
[NCBI]
|
9.23074e-05
|
|
|
SPG33
|
[NCBI]
|
9.23074e-05
|
|
|
CDG1L
|
[NCBI]
|
9.23074e-05
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
9.23074e-05
|
|
|
van buchem disease, type 2
|
[NCBI]
|
9.23074e-05
|
|
|
LCCS3
|
[NCBI]
|
9.23074e-05
|
|
|
ADCAD2
|
[NCBI]
|
9.23074e-05
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
9.23074e-05
|
|
|
POF5
|
[NCBI]
|
9.23074e-05
|
|
|
ectopia pupillae
|
[NCBI]
|
9.23074e-05
|
|
|
CISS2
|
[NCBI]
|
9.23074e-05
|
|
|
SCN5A
|
[NCBI]
|
9.05476e-05
|
|
|
currarino syndrome
|
[NCBI]
|
9.05336e-05
|
|
|
EDM4
|
[NCBI]
|
9.05336e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
9.05336e-05
|
|
|
CRH
|
[NCBI]
|
8.82048e-05
|
|
|
RYR1
|
[NCBI]
|
8.7816e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
8.59925e-05
|
|
|
HFE4
|
[NCBI]
|
8.59925e-05
|
|
|
SRS
|
[NCBI]
|
8.58429e-05
|
|
|
MC1R
|
[NCBI]
|
8.51667e-05
|
|
|
FPLD2
|
[NCBI]
|
8.51498e-05
|
|
|
APP
|
[NCBI]
|
8.12052e-05
|
|
|
CEACAM5
|
[NCBI]
|
8.00838e-05
|
|
|
PPARG
|
[NCBI]
|
7.97894e-05
|
|
|
TH
|
[NCBI]
|
7.875e-05
|
|
|
CMT4A
|
[NCBI]
|
7.83254e-05
|
|
|
AIS
|
[NCBI]
|
7.82933e-05
|
|
|
NPPA
|
[NCBI]
|
7.50599e-05
|
|
|
pick disease of brain
|
[NCBI]
|
7.50306e-05
|
|
|
OPPG
|
[NCBI]
|
7.50306e-05
|
|
|
ACH
|
[NCBI]
|
7.45639e-05
|
|
|
CHAT
|
[NCBI]
|
7.42198e-05
|
|
|
PWS
|
[NCBI]
|
7.22151e-05
|
|
|
LQT3
|
[NCBI]
|
7.2017e-05
|
|
|
LGMD2I
|
[NCBI]
|
7.2017e-05
|
|
|
JME
|
[NCBI]
|
7.2017e-05
|
|
|
ARMD4
|
[NCBI]
|
7.2017e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
7.10166e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
6.98899e-05
|
|
|
LMS
|
[NCBI]
|
6.92426e-05
|
|
|
FBN1
|
[NCBI]
|
6.86821e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
6.82933e-05
|
|
|
CFTR
|
[NCBI]
|
6.73553e-05
|
|
|
VMD
|
[NCBI]
|
6.7027e-05
|
|
|
DLB
|
[NCBI]
|
6.66742e-05
|
|
|
MECP2
|
[NCBI]
|
6.65983e-05
|
|
|
HGF
|
[NCBI]
|
6.47595e-05
|
|
|
APC
|
[NCBI]
|
6.4736e-05
|
|
|
WFS2
|
[NCBI]
|
6.47342e-05
|
|
|
ARMD3
|
[NCBI]
|
6.47342e-05
|
|
|
SIDDT
|
[NCBI]
|
6.47342e-05
|
|
|
NFTC
|
[NCBI]
|
6.47342e-05
|
|
|
atrial standstill
|
[NCBI]
|
6.47342e-05
|
|
|
GLC1G
|
[NCBI]
|
6.47342e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
6.47342e-05
|
|
|
glycine n-methyltransferase deficiency
|
[NCBI]
|
6.47342e-05
|
|
|
nevus, keratinocytic, nonepidermolytic
|
[NCBI]
|
6.47342e-05
|
|
|
ASD2
|
[NCBI]
|
6.47342e-05
|
|
|
CMH8
|
[NCBI]
|
6.47342e-05
|
|
|
scapuloperoneal myopathy, x-linked dominant
|
[NCBI]
|
6.47342e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
6.47342e-05
|
|
|
erythrocytosis, familial, 3
|
[NCBI]
|
6.47342e-05
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
6.47342e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
6.47342e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
6.47342e-05
|
|
|
AKV
|
[NCBI]
|
6.47342e-05
|
|
|
deafness, autosomal dominant nonsyndromic sensorineural, due to mutation in myo1a
|
[NCBI]
|
6.47342e-05
|
|
|
HMN7B
|
[NCBI]
|
6.47342e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
6.47342e-05
|
|
|
AME2
|
[NCBI]
|
6.47342e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
6.47342e-05
|
|
|
CORD2
|
[NCBI]
|
6.42851e-05
|
|
|
longevity
|
[NCBI]
|
6.42851e-05
|
|
|
EEC3
|
[NCBI]
|
6.42851e-05
|
|
|
SPG2
|
[NCBI]
|
6.42851e-05
|
|
|
COQ2
|
[NCBI]
|
6.36093e-05
|
|
|
KCNA1
|
[NCBI]
|
6.34594e-05
|
|
|
EPO
|
[NCBI]
|
6.2937e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
6.20535e-05
|
|
|
EAOH
|
[NCBI]
|
6.20535e-05
|
|
|
ANG
|
[NCBI]
|
6.18935e-05
|
|
|
CJD
|
[NCBI]
|
6.1656e-05
|
|
|
PTH
|
[NCBI]
|
6.16271e-05
|
|
|
NPY
|
[NCBI]
|
6.10636e-05
|
|
|
COL7A1
|
[NCBI]
|
6.03485e-05
|
|
|
EBN1
|
[NCBI]
|
5.99612e-05
|
|
|
GEFS+
|
[NCBI]
|
5.99612e-05
|
|
|
IBM2
|
[NCBI]
|
5.99612e-05
|
|
|
SLC4A1
|
[NCBI]
|
5.97495e-05
|
|
|
ZFPM1
|
[NCBI]
|
5.8942e-05
|
|
|
CAV3
|
[NCBI]
|
5.81959e-05
|
|
|
PARK8
|
[NCBI]
|
5.79932e-05
|
|
|
VIP
|
[NCBI]
|
5.78108e-05
|
|
|
MPO
|
[NCBI]
|
5.77379e-05
|
|
|
TSHR
|
[NCBI]
|
5.7247e-05
|
|
|
KCNH2
|
[NCBI]
|
5.70863e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
5.61367e-05
|
|
|
KIT
|
[NCBI]
|
5.57744e-05
|
|
|
TNFSF6
|
[NCBI]
|
5.54889e-05
|
|
|
PCNA
|
[NCBI]
|
5.52029e-05
|
|
|
GJB2
|
[NCBI]
|
5.48363e-05
|
|
|
FMO3
|
[NCBI]
|
5.4627e-05
|
|
|
PSEN2
|
[NCBI]
|
5.45857e-05
|
|
|
ALPS2A
|
[NCBI]
|
5.44519e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
5.44519e-05
|
|
|
LVNCX
|
[NCBI]
|
5.44519e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
5.44519e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
5.44519e-05
|
|
|
coats disease
|
[NCBI]
|
5.44519e-05
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
5.44519e-05
|
|
|
EDMD3
|
[NCBI]
|
5.44519e-05
|
|
|
MRX63
|
[NCBI]
|
5.44519e-05
|
|
|
HANAC
|
[NCBI]
|
5.44519e-05
|
|
|
bile acid synthesis defect, congenital, 4
|
[NCBI]
|
5.44519e-05
|
|
|
COD3
|
[NCBI]
|
5.44519e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
5.44519e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
5.44519e-05
|
|
|
HMERF
|
[NCBI]
|
5.44519e-05
|
|
|
DFNA36
|
[NCBI]
|
5.44519e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
5.44519e-05
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
5.44519e-05
|
|
|
CMD1P
|
[NCBI]
|
5.44519e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
5.44519e-05
|
|
|
blood group--froese
|
[NCBI]
|
5.44519e-05
|
|
|
SLEB2
|
[NCBI]
|
5.44519e-05
|
|
|
ACHE
|
[NCBI]
|
5.3258e-05
|
|
|
PSNP1
|
[NCBI]
|
5.27158e-05
|
|
|
GJB1
|
[NCBI]
|
5.27123e-05
|
|
|
RMD
|
[NCBI]
|
5.11341e-05
|
|
|
FMF
|
[NCBI]
|
4.83736e-05
|
|
|
porphyria variegata
|
[NCBI]
|
4.81705e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
4.7845e-05
|
|
|
OPTA1
|
[NCBI]
|
4.7845e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
4.7845e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
4.7845e-05
|
|
|
CSNBAD1
|
[NCBI]
|
4.7845e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
4.7845e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
4.7845e-05
|
|
|
atransferrinemia
|
[NCBI]
|
4.7845e-05
|
|
|
CMM3
|
[NCBI]
|
4.7845e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
4.7845e-05
|
|
|
HHF3
|
[NCBI]
|
4.7845e-05
|
|
|
FSGS2
|
[NCBI]
|
4.7845e-05
|
|
|
ASAT
|
[NCBI]
|
4.7845e-05
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
4.7845e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
4.7845e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
4.7845e-05
|
|
|
SCA27
|
[NCBI]
|
4.7845e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
4.7845e-05
|
|
|
SPG7
|
[NCBI]
|
4.7845e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
4.7845e-05
|
|
|
POLG
|
[NCBI]
|
4.73996e-05
|
|
|
PMM2
|
[NCBI]
|
4.71331e-05
|
|
|
EVC
|
[NCBI]
|
4.68204e-05
|
|
|
FSHR
|
[NCBI]
|
4.64944e-05
|
|
|
HFE
|
[NCBI]
|
4.48527e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
4.43989e-05
|
|
|
CENTB1
|
[NCBI]
|
4.43712e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
4.42507e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
4.36884e-05
|
|
|
ALS1
|
[NCBI]
|
4.36884e-05
|
|
|
SNCA
|
[NCBI]
|
4.35685e-05
|
|
|
CRC
|
[NCBI]
|
4.35423e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
4.35308e-05
|
|
|
RP
|
[NCBI]
|
4.31964e-05
|
|
|
MB
|
[NCBI]
|
4.30194e-05
|
|
|
FCDT
|
[NCBI]
|
4.29836e-05
|
|
|
ALSG
|
[NCBI]
|
4.29836e-05
|
|
|
NEM1
|
[NCBI]
|
4.29836e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
4.29836e-05
|
|
|
witkop syndrome
|
[NCBI]
|
4.29836e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
4.29836e-05
|
|
|
EBDSC
|
[NCBI]
|
4.29836e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
4.29836e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
4.29836e-05
|
|
|
CMD1D
|
[NCBI]
|
4.29836e-05
|
|
|
hyperostosis corticalis generalisata, benign form of worth, with torus palatinus
|
[NCBI]
|
4.29836e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
4.29836e-05
|
|
|
HCHOLA3
|
[NCBI]
|
4.29836e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
4.29836e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
4.29836e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
4.29836e-05
|
|
|
DFNA17
|
[NCBI]
|
4.29836e-05
|
|
|
PRKAG2
|
[NCBI]
|
4.22925e-05
|
|
|
PRKCM
|
[NCBI]
|
4.2123e-05
|
|
|
ABL1
|
[NCBI]
|
4.17929e-05
|
|
|
INSL3
|
[NCBI]
|
4.12971e-05
|
|
|
PLN
|
[NCBI]
|
4.12866e-05
|
|
|
PTPN11
|
[NCBI]
|
4.04596e-05
|
|
|
MAPT
|
[NCBI]
|
4.03807e-05
|
|
|
LGMD2A
|
[NCBI]
|
3.97005e-05
|
|
|
CCD
|
[NCBI]
|
3.9698e-05
|
|
|
SLC25A1
|
[NCBI]
|
3.95276e-05
|
|
|
M6PRBP1
|
[NCBI]
|
3.92921e-05
|
|
|
STHAG1
|
[NCBI]
|
3.91503e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
3.91503e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
3.91503e-05
|
|
|
ADCC
|
[NCBI]
|
3.91503e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
3.91503e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
3.91503e-05
|
|
|
FPLD3
|
[NCBI]
|
3.91503e-05
|
|
|
RP14
|
[NCBI]
|
3.91503e-05
|
|
|
goldberg-shprintzen megacolon syndrome
|
[NCBI]
|
3.91503e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
3.91503e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
3.91503e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
3.91503e-05
|
|
|
CML
|
[NCBI]
|
3.86677e-05
|
|
|
EVA
|
[NCBI]
|
3.86677e-05
|
|
|
COCH
|
[NCBI]
|
3.83027e-05
|
|
|
RTT
|
[NCBI]
|
3.82548e-05
|
|
|
NS1
|
[NCBI]
|
3.78619e-05
|
|
|
CADASIL
|
[NCBI]
|
3.76717e-05
|
|
|
PCTT
|
[NCBI]
|
3.76717e-05
|
|
|
GATA1
|
[NCBI]
|
3.71741e-05
|
|
|
ELAC2
|
[NCBI]
|
3.71638e-05
|
|
|
BEST1
|
[NCBI]
|
3.71638e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.65768e-05
|
|
|
APOBEC3G
|
[NCBI]
|
3.61001e-05
|
|
|
JAG1
|
[NCBI]
|
3.5997e-05
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
3.59963e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
3.59963e-05
|
|
|
amme complex
|
[NCBI]
|
3.59963e-05
|
|
|
TD2
|
[NCBI]
|
3.59963e-05
|
|
|
CPVT
|
[NCBI]
|
3.59963e-05
|
|
|
F5F8D
|
[NCBI]
|
3.59963e-05
|
|
|
IDDM5
|
[NCBI]
|
3.59963e-05
|
|
|
CORD3
|
[NCBI]
|
3.59963e-05
|
|
|
body mass index
|
[NCBI]
|
3.59963e-05
|
|
|
EAD
|
[NCBI]
|
3.59963e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
3.59963e-05
|
|
|
CDG1C
|
[NCBI]
|
3.59963e-05
|
|
|
pierson syndrome
|
[NCBI]
|
3.59963e-05
|
|
|
ESRRG
|
[NCBI]
|
3.58227e-05
|
|
|
SUPT5H
|
[NCBI]
|
3.58227e-05
|
|
|
HIST2H2BE
|
[NCBI]
|
3.58227e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
3.57819e-05
|
|
|
JMML
|
[NCBI]
|
3.55604e-05
|
|
|
wilson disease
|
[NCBI]
|
3.55604e-05
|
|
|
BHMT
|
[NCBI]
|
3.51027e-05
|
|
|
PMD
|
[NCBI]
|
3.50696e-05
|
|
|
EIG
|
[NCBI]
|
3.50696e-05
|
|
|
ATP7B
|
[NCBI]
|
3.48862e-05
|
|
|
HYPP
|
[NCBI]
|
3.48844e-05
|
|
|
MYOC
|
[NCBI]
|
3.42864e-05
|
|
|
KCNJ2
|
[NCBI]
|
3.4164e-05
|
|
|
KCNE1
|
[NCBI]
|
3.4164e-05
|
|
|
LRRK2
|
[NCBI]
|
3.34486e-05
|
|
|
SCN4A
|
[NCBI]
|
3.33301e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
3.33252e-05
|
|
|
CHED2
|
[NCBI]
|
3.33252e-05
|
|
|
myopathy, myosin storage
|
[NCBI]
|
3.33252e-05
|
|
|
VMCM
|
[NCBI]
|
3.33252e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
3.33252e-05
|
|
|
IDD
|
[NCBI]
|
3.33252e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
3.33252e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
3.33252e-05
|
|
|
LADD
|
[NCBI]
|
3.33252e-05
|
|
|
RAG2
|
[NCBI]
|
3.32779e-05
|
|
|
NEU1
|
[NCBI]
|
3.32779e-05
|
|
|
PCSK7
|
[NCBI]
|
3.3177e-05
|
|
|
EGLN1
|
[NCBI]
|
3.3177e-05
|
|
|
ALG6
|
[NCBI]
|
3.3177e-05
|
|
|
SMEI
|
[NCBI]
|
3.31757e-05
|
|
|
PXE
|
[NCBI]
|
3.23306e-05
|
|
|
EGFR
|
[NCBI]
|
3.18767e-05
|
|
|
BCHE
|
[NCBI]
|
3.18415e-05
|
|
|
CYCS
|
[NCBI]
|
3.1643e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
3.13813e-05
|
|
|
KCNE3
|
[NCBI]
|
3.10384e-05
|
|
|
KCNA2
|
[NCBI]
|
3.10384e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
3.10151e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
3.10151e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
3.10151e-05
|
|
|
DFNA3
|
[NCBI]
|
3.10151e-05
|
|
|
FTC
|
[NCBI]
|
3.10151e-05
|
|
|
RP12
|
[NCBI]
|
3.10151e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
3.10151e-05
|
|
|
por deficiency
|
[NCBI]
|
3.10151e-05
|
|
|
HFE3
|
[NCBI]
|
3.10151e-05
|
|
|
SBS
|
[NCBI]
|
3.10151e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
3.10151e-05
|
|
|
SPG10
|
[NCBI]
|
3.10151e-05
|
|
|
HHF6
|
[NCBI]
|
3.10151e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
3.10151e-05
|
|
|
CFH
|
[NCBI]
|
3.09127e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.08074e-05
|
|
|
RTS
|
[NCBI]
|
3.08074e-05
|
|
|
MTHFR
|
[NCBI]
|
3.05101e-05
|
|
|
EDMD
|
[NCBI]
|
3.0065e-05
|
|
|
FFI
|
[NCBI]
|
2.95153e-05
|
|
|
FKRP
|
[NCBI]
|
2.94747e-05
|
|
|
EGR2
|
[NCBI]
|
2.94747e-05
|
|
|
SCS
|
[NCBI]
|
2.93443e-05
|
|
|
NLGN3
|
[NCBI]
|
2.92448e-05
|
|
|
PIP5K1C
|
[NCBI]
|
2.92448e-05
|
|
|
LGR8
|
[NCBI]
|
2.92448e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
2.89852e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
2.89852e-05
|
|
|
DFNB9
|
[NCBI]
|
2.89852e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
2.89852e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
2.89852e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
2.89852e-05
|
|
|
JWS
|
[NCBI]
|
2.89852e-05
|
|
|
PBT
|
[NCBI]
|
2.89852e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
2.89852e-05
|
|
|
CLN8
|
[NCBI]
|
2.89852e-05
|
|
|
SMMCI
|
[NCBI]
|
2.89852e-05
|
|
|
pta deficiency
|
[NCBI]
|
2.88153e-05
|
|
|
udp-glucose:glycoprotein glucosyltransferase 2
|
[NCBI]
|
2.78369e-05
|
|
|
C4ORF20
|
[NCBI]
|
2.78369e-05
|
|
|
INTS7
|
[NCBI]
|
2.78369e-05
|
|
|
TMEM2
|
[NCBI]
|
2.78369e-05
|
|
|
SAMD8
|
[NCBI]
|
2.78369e-05
|
|
|
CISD2
|
[NCBI]
|
2.78369e-05
|
|
|
otospiralin
|
[NCBI]
|
2.78369e-05
|
|
|
INTS3
|
[NCBI]
|
2.78369e-05
|
|
|
ufm1-specific protease 1
|
[NCBI]
|
2.78369e-05
|
|
|
INTS12
|
[NCBI]
|
2.78369e-05
|
|
|
udp-glucose:glycoprotein glucosyltransferase 1
|
[NCBI]
|
2.78369e-05
|
|
|
INTS10
|
[NCBI]
|
2.78369e-05
|
|
|
NUDCD1
|
[NCBI]
|
2.78369e-05
|
|
|
GALNT8
|
[NCBI]
|
2.78369e-05
|
|
|
SGMS2
|
[NCBI]
|
2.78369e-05
|
|
|
GDPD5
|
[NCBI]
|
2.78369e-05
|
|
|
INTS8
|
[NCBI]
|
2.78369e-05
|
|
|
FBXL15
|
[NCBI]
|
2.78369e-05
|
|
|
INTS4
|
[NCBI]
|
2.78369e-05
|
|
|
PLP1
|
[NCBI]
|
2.77612e-05
|
|
|
COL9A2
|
[NCBI]
|
2.77018e-05
|
|
|
PEX13
|
[NCBI]
|
2.77018e-05
|
|
|
CHRND
|
[NCBI]
|
2.77018e-05
|
|
|
HNF1A
|
[NCBI]
|
2.76601e-05
|
|
|
BDA1
|
[NCBI]
|
2.71792e-05
|
|
|
SCAR1
|
[NCBI]
|
2.71792e-05
|
|
|
CDL1
|
[NCBI]
|
2.71792e-05
|
|
|
SCA14
|
[NCBI]
|
2.71792e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
2.71792e-05
|
|
|
HTX1
|
[NCBI]
|
2.71792e-05
|
|
|
scheie syndrome
|
[NCBI]
|
2.71792e-05
|
|
|
CMT2A2
|
[NCBI]
|
2.71792e-05
|
|
|
DFNA12
|
[NCBI]
|
2.71792e-05
|
|
|
RHO
|
[NCBI]
|
2.65174e-05
|
|
|
RYR2
|
[NCBI]
|
2.64339e-05
|
|
|
TP73L
|
[NCBI]
|
2.64339e-05
|
|
|
RP1
|
[NCBI]
|
2.63493e-05
|
|
|
GBE1
|
[NCBI]
|
2.63493e-05
|
|
|
IMPDH1
|
[NCBI]
|
2.63493e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.63405e-05
|
|
|
MHS1
|
[NCBI]
|
2.6034e-05
|
|
|
NOS3
|
[NCBI]
|
2.60025e-05
|
|
|
NPC1
|
[NCBI]
|
2.58939e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.58939e-05
|
|
|
TWIST1
|
[NCBI]
|
2.58939e-05
|
|
|
CDA
|
[NCBI]
|
2.55561e-05
|
|
|
MRXS13
|
[NCBI]
|
2.55561e-05
|
|
|
SACS
|
[NCBI]
|
2.55561e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
2.55561e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
2.55561e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
2.55561e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
2.55561e-05
|
|
|
HHS
|
[NCBI]
|
2.55561e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
2.55561e-05
|
|
|
MERRF
|
[NCBI]
|
2.55561e-05
|
|
|
RHS
|
[NCBI]
|
2.55561e-05
|
|
|
medulloblastoma
|
[NCBI]
|
2.55561e-05
|
|
|
LMNA
|
[NCBI]
|
2.53964e-05
|
|
|
CAPN3
|
[NCBI]
|
2.53731e-05
|
|
|
CYP27A1
|
[NCBI]
|
2.51464e-05
|
|
|
FGD1
|
[NCBI]
|
2.51464e-05
|
|
|
UGT1A1
|
[NCBI]
|
2.50259e-05
|
|
|
PMP22
|
[NCBI]
|
2.47692e-05
|
|
|
MBP
|
[NCBI]
|
2.46203e-05
|
|
|
NM
|
[NCBI]
|
2.40854e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
2.40854e-05
|
|
|
THC2
|
[NCBI]
|
2.40854e-05
|
|
|
EDM1
|
[NCBI]
|
2.40854e-05
|
|
|
adult syndrome
|
[NCBI]
|
2.40854e-05
|
|
|
FTNS
|
[NCBI]
|
2.40854e-05
|
|
|
BMND1
|
[NCBI]
|
2.40854e-05
|
|
|
AEZ
|
[NCBI]
|
2.40854e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
2.40854e-05
|
|
|
ED2
|
[NCBI]
|
2.40854e-05
|
|
|
LGI1
|
[NCBI]
|
2.30819e-05
|
|
|
CHRNB2
|
[NCBI]
|
2.30819e-05
|
|
|
AVPR2
|
[NCBI]
|
2.30192e-05
|
|
|
LPG
|
[NCBI]
|
2.27436e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
2.27436e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.27436e-05
|
|
|
EA1
|
[NCBI]
|
2.27436e-05
|
|
|
HFTC
|
[NCBI]
|
2.27436e-05
|
|
|
JLNS1
|
[NCBI]
|
2.27436e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
2.27436e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
2.27436e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
2.27436e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
2.27436e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
2.27436e-05
|
|
|
RAG1
|
[NCBI]
|
2.2592e-05
|
|
|
FGG
|
[NCBI]
|
2.2592e-05
|
|
|
RAMP1
|
[NCBI]
|
2.21829e-05
|
|
|
TPH2
|
[NCBI]
|
2.21829e-05
|
|
|
HGD
|
[NCBI]
|
2.21829e-05
|
|
|
ABCC8
|
[NCBI]
|
2.21271e-05
|
|
|
LQT1
|
[NCBI]
|
2.20873e-05
|
|
|
PD
|
[NCBI]
|
2.19761e-05
|
|
|
PTHLH
|
[NCBI]
|
2.18685e-05
|
|
|
HNMT
|
[NCBI]
|
2.17751e-05
|
|
|
JAK2
|
[NCBI]
|
2.16104e-05
|
|
|
ADLTE
|
[NCBI]
|
2.15121e-05
|
|
|
BHC
|
[NCBI]
|
2.15121e-05
|
|
|
CTHM
|
[NCBI]
|
2.15121e-05
|
|
|
SCZD4
|
[NCBI]
|
2.15121e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
2.15121e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
2.15121e-05
|
|
|
CFTD
|
[NCBI]
|
2.15121e-05
|
|
|
JH
|
[NCBI]
|
2.15121e-05
|
|
|
omenn syndrome
|
[NCBI]
|
2.15121e-05
|
|
|
SOST
|
[NCBI]
|
2.15121e-05
|
|
|
P2RX7
|
[NCBI]
|
2.1355e-05
|
|
|
SCN2A
|
[NCBI]
|
2.1355e-05
|
|
|
AS
|
[NCBI]
|
2.1204e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.1204e-05
|
|
|
GAA
|
[NCBI]
|
2.1004e-05
|
|
|
CDA
|
[NCBI]
|
2.1004e-05
|
|
|
OTOF
|
[NCBI]
|
2.05882e-05
|
|
|
GDAP1
|
[NCBI]
|
2.05882e-05
|
|
|
NLK
|
[NCBI]
|
2.05882e-05
|
|
|
KCNQ2
|
[NCBI]
|
2.05882e-05
|
|
|
SPG3A
|
[NCBI]
|
2.05882e-05
|
|
|
TAP1
|
[NCBI]
|
2.05882e-05
|
|
|
oncogene dj1
|
[NCBI]
|
2.05882e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
2.03763e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
2.03763e-05
|
|
|
PARK6
|
[NCBI]
|
2.03763e-05
|
|
|
CMDD
|
[NCBI]
|
2.03763e-05
|
|
|
GCE
|
[NCBI]
|
2.03763e-05
|
|
|
alexander disease
|
[NCBI]
|
2.03763e-05
|
|
|
MTCYB
|
[NCBI]
|
2.02746e-05
|
|
|
NIDDM
|
[NCBI]
|
2.01251e-05
|
|
|
THBD
|
[NCBI]
|
1.98747e-05
|
|
|
RAPSN
|
[NCBI]
|
1.98747e-05
|
|
|
ATP1A2
|
[NCBI]
|
1.98747e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.98747e-05
|
|
|
TD1
|
[NCBI]
|
1.96634e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.96634e-05
|
|
|
TRIM23
|
[NCBI]
|
1.96448e-05
|
|
|
ZNF214
|
[NCBI]
|
1.96448e-05
|
|
|
INTS1
|
[NCBI]
|
1.96448e-05
|
|
|
HHAT
|
[NCBI]
|
1.96448e-05
|
|
|
GTF2H4
|
[NCBI]
|
1.96448e-05
|
|
|
INTS2
|
[NCBI]
|
1.96448e-05
|
|
|
CPSF3L
|
[NCBI]
|
1.96448e-05
|
|
|
YKT6
|
[NCBI]
|
1.96448e-05
|
|
|
INTS9
|
[NCBI]
|
1.96448e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.96448e-05
|
|
|
AP3S2
|
[NCBI]
|
1.96448e-05
|
|
|
TGFBRAP1
|
[NCBI]
|
1.96448e-05
|
|
|
INTS5
|
[NCBI]
|
1.96448e-05
|
|
|
LRRK1
|
[NCBI]
|
1.96448e-05
|
|
|
ZFYVE27
|
[NCBI]
|
1.96448e-05
|
|
|
ZNF674
|
[NCBI]
|
1.96448e-05
|
|
|
MYO1A
|
[NCBI]
|
1.96448e-05
|
|
|
ZNF673
|
[NCBI]
|
1.96448e-05
|
|
|
AGGF1
|
[NCBI]
|
1.96448e-05
|
|
|
ZNF215
|
[NCBI]
|
1.96448e-05
|
|
|
MMAA
|
[NCBI]
|
1.96448e-05
|
|
|
MASTL
|
[NCBI]
|
1.96448e-05
|
|
|
PTP4A3
|
[NCBI]
|
1.96448e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.96448e-05
|
|
|
refsum disease
|
[NCBI]
|
1.93241e-05
|
|
|
RSMD1
|
[NCBI]
|
1.93241e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
1.93241e-05
|
|
|
ICP
|
[NCBI]
|
1.93241e-05
|
|
|
DHRD
|
[NCBI]
|
1.93241e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.93241e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
1.93241e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.93241e-05
|
|
|
acromegaly
|
[NCBI]
|
1.93241e-05
|
|
|
TMAU
|
[NCBI]
|
1.93241e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.92502e-05
|
|
|
CRX
|
[NCBI]
|
1.9208e-05
|
|
|
FGB
|
[NCBI]
|
1.9208e-05
|
|
|
RET
|
[NCBI]
|
1.91854e-05
|
|
|
HD
|
[NCBI]
|
1.89215e-05
|
|
|
HBG2
|
[NCBI]
|
1.86093e-05
|
|
|
ACADVL
|
[NCBI]
|
1.85826e-05
|
|
|
TPM3
|
[NCBI]
|
1.85826e-05
|
|
|
GLRA1
|
[NCBI]
|
1.85826e-05
|
|
|
ACTA1
|
[NCBI]
|
1.85826e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
1.83457e-05
|
|
|
ABS
|
[NCBI]
|
1.83457e-05
|
|
|
GABEB
|
[NCBI]
|
1.83457e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
1.83457e-05
|
|
|
FHM2
|
[NCBI]
|
1.83457e-05
|
|
|
SHEP2
|
[NCBI]
|
1.83457e-05
|
|
|
FTD
|
[NCBI]
|
1.82242e-05
|
|
|
AT
|
[NCBI]
|
1.8188e-05
|
|
|
CACNA1A
|
[NCBI]
|
1.79988e-05
|
|
|
HDAC6
|
[NCBI]
|
1.79941e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.79941e-05
|
|
|
PRKCG
|
[NCBI]
|
1.79941e-05
|
|
|
AMELX
|
[NCBI]
|
1.74388e-05
|
|
|
CYGB
|
[NCBI]
|
1.74388e-05
|
|
|
KAL2
|
[NCBI]
|
1.74329e-05
|
|
|
BFLS
|
[NCBI]
|
1.74329e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.74329e-05
|
|
|
PCLD
|
[NCBI]
|
1.74329e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
1.74329e-05
|
|
|
ESCS
|
[NCBI]
|
1.74329e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
1.74329e-05
|
|
|
FLNA
|
[NCBI]
|
1.71349e-05
|
|
|
PON1
|
[NCBI]
|
1.69734e-05
|
|
|
GJB6
|
[NCBI]
|
1.69132e-05
|
|
|
MYH7
|
[NCBI]
|
1.65906e-05
|
|
|
MYOZ2
|
[NCBI]
|
1.65873e-05
|
|
|
ectodysplasin receptor, x-linked
|
[NCBI]
|
1.65873e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.65873e-05
|
|
|
ALG9
|
[NCBI]
|
1.65873e-05
|
|
|
PHGDH
|
[NCBI]
|
1.65873e-05
|
|
|
NHP2L1
|
[NCBI]
|
1.65873e-05
|
|
|
EGLN3
|
[NCBI]
|
1.65873e-05
|
|
|
CDC42EP1
|
[NCBI]
|
1.65873e-05
|
|
|
DMGDH
|
[NCBI]
|
1.65873e-05
|
|
|
MMSDH
|
[NCBI]
|
1.65873e-05
|
|
|
AKAP10
|
[NCBI]
|
1.65873e-05
|
|
|
CLCF1
|
[NCBI]
|
1.65873e-05
|
|
|
nebulette
|
[NCBI]
|
1.65873e-05
|
|
|
CTH
|
[NCBI]
|
1.65873e-05
|
|
|
SESN2
|
[NCBI]
|
1.65873e-05
|
|
|
CA11
|
[NCBI]
|
1.65873e-05
|
|
|
ACCN4
|
[NCBI]
|
1.65873e-05
|
|
|
PIP5K1A
|
[NCBI]
|
1.65873e-05
|
|
|
COL4A3BP
|
[NCBI]
|
1.65873e-05
|
|
|
SGMS1
|
[NCBI]
|
1.65873e-05
|
|
|
AP3S1
|
[NCBI]
|
1.65873e-05
|
|
|
NOBOX
|
[NCBI]
|
1.65873e-05
|
|
|
EGLN2
|
[NCBI]
|
1.65873e-05
|
|
|
MTTA
|
[NCBI]
|
1.65873e-05
|
|
|
HISPPD1
|
[NCBI]
|
1.65873e-05
|
|
|
PKDREJ
|
[NCBI]
|
1.65873e-05
|
|
|
GALM
|
[NCBI]
|
1.65873e-05
|
|
|
SAMD9
|
[NCBI]
|
1.65873e-05
|
|
|
RAD51C
|
[NCBI]
|
1.65873e-05
|
|
|
ZRF1
|
[NCBI]
|
1.65873e-05
|
|
|
TOMM70A
|
[NCBI]
|
1.65873e-05
|
|
|
WDR36
|
[NCBI]
|
1.65873e-05
|
|
|
CENTB2
|
[NCBI]
|
1.65873e-05
|
|
|
UFM1
|
[NCBI]
|
1.65873e-05
|
|
|
CD207
|
[NCBI]
|
1.65873e-05
|
|
|
HYAL3
|
[NCBI]
|
1.65873e-05
|
|
|
C14ORF58
|
[NCBI]
|
1.65873e-05
|
|
|
MTRNR2
|
[NCBI]
|
1.65873e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.65788e-05
|
|
|
PMC
|
[NCBI]
|
1.65788e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.65788e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
1.65788e-05
|
|
|
ORW2
|
[NCBI]
|
1.65788e-05
|
|
|
MPL
|
[NCBI]
|
1.64148e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.64148e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.64148e-05
|
|
|
GATA4
|
[NCBI]
|
1.64148e-05
|
|
|
IBD1
|
[NCBI]
|
1.63305e-05
|
|
|
PSACH
|
[NCBI]
|
1.63305e-05
|
|
|
SHH
|
[NCBI]
|
1.62222e-05
|
|
|
GDNF
|
[NCBI]
|
1.6185e-05
|
|
|
PAX8
|
[NCBI]
|
1.5941e-05
|
|
|
RHD
|
[NCBI]
|
1.5941e-05
|
|
|
APTX
|
[NCBI]
|
1.5941e-05
|
|
|
LAMB3
|
[NCBI]
|
1.5941e-05
|
|
|
DLD
|
[NCBI]
|
1.5941e-05
|
|
|
NKX2-1
|
[NCBI]
|
1.5941e-05
|
|
|
GLC3A
|
[NCBI]
|
1.57775e-05
|
|
|
APL
|
[NCBI]
|
1.57775e-05
|
|
|
EBR1
|
[NCBI]
|
1.57775e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
1.57775e-05
|
|
|
TLR4
|
[NCBI]
|
1.55649e-05
|
|
|
POMC
|
[NCBI]
|
1.55566e-05
|
|
|
TGFBI
|
[NCBI]
|
1.54898e-05
|
|
|
EMD
|
[NCBI]
|
1.54898e-05
|
|
|
MSX1
|
[NCBI]
|
1.54898e-05
|
|
|
EDA
|
[NCBI]
|
1.54898e-05
|
|
|
PINK1
|
[NCBI]
|
1.54898e-05
|
|
|
PYY
|
[NCBI]
|
1.52211e-05
|
|
|
RNASE3
|
[NCBI]
|
1.51961e-05
|
|
|
LRP5
|
[NCBI]
|
1.50593e-05
|
|
|
MYH9
|
[NCBI]
|
1.50593e-05
|
|
|
CASR
|
[NCBI]
|
1.50344e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
1.50239e-05
|
|
|
donohue syndrome
|
[NCBI]
|
1.50239e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
1.50239e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
1.50239e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
1.50239e-05
|
|
|
CNTF
|
[NCBI]
|
1.49567e-05
|
|
|
ITGB3
|
[NCBI]
|
1.48584e-05
|
|
|
SCN1A
|
[NCBI]
|
1.46478e-05
|
|
|
COLEC12
|
[NCBI]
|
1.46212e-05
|
|
|
CYP4F12
|
[NCBI]
|
1.46212e-05
|
|
|
ARHGAP8
|
[NCBI]
|
1.46212e-05
|
|
|
UPF2
|
[NCBI]
|
1.46212e-05
|
|
|
AQP6
|
[NCBI]
|
1.46212e-05
|
|
|
deleted in split-hand/split-foot 1 region
|
[NCBI]
|
1.46212e-05
|
|
|
HISPPD2A
|
[NCBI]
|
1.46212e-05
|
|
|
PDSS1
|
[NCBI]
|
1.46212e-05
|
|
|
HES6
|
[NCBI]
|
1.46212e-05
|
|
|
SLC25A15
|
[NCBI]
|
1.46212e-05
|
|
|
TRIB3
|
[NCBI]
|
1.46212e-05
|
|
|
CD109
|
[NCBI]
|
1.46212e-05
|
|
|
NBR1
|
[NCBI]
|
1.46212e-05
|
|
|
AP3D1
|
[NCBI]
|
1.46212e-05
|
|
|
NKX2-6
|
[NCBI]
|
1.46212e-05
|
|
|
SUPT4H1
|
[NCBI]
|
1.46212e-05
|
|
|
IFNA17
|
[NCBI]
|
1.46212e-05
|
|
|
CYP4F8
|
[NCBI]
|
1.46212e-05
|
|
|
PMAIP1
|
[NCBI]
|
1.46212e-05
|
|
|
PTHR2
|
[NCBI]
|
1.46212e-05
|
|
|
RAB9
|
[NCBI]
|
1.46212e-05
|
|
|
MPP5
|
[NCBI]
|
1.46212e-05
|
|
|
IRS1
|
[NCBI]
|
1.44071e-05
|
|
|
PCI
|
[NCBI]
|
1.43677e-05
|
|
|
TS
|
[NCBI]
|
1.43579e-05
|
|
|
MLC
|
[NCBI]
|
1.43138e-05
|
|
|
MADA
|
[NCBI]
|
1.43138e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.43138e-05
|
|
|
CHNG2
|
[NCBI]
|
1.43138e-05
|
|
|
TGD
|
[NCBI]
|
1.43138e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
1.43138e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.42541e-05
|
|
|
PTPN1
|
[NCBI]
|
1.42541e-05
|
|
|
WAS
|
[NCBI]
|
1.41285e-05
|
|
|
PPIB
|
[NCBI]
|
1.38766e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.38766e-05
|
|
|
TNNT2
|
[NCBI]
|
1.38766e-05
|
|
|
PROP1
|
[NCBI]
|
1.38766e-05
|
|
|
PPARA
|
[NCBI]
|
1.38593e-05
|
|
|
CRMO
|
[NCBI]
|
1.36433e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.36433e-05
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
1.36433e-05
|
|
|
alcohol dependence
|
[NCBI]
|
1.36433e-05
|
|
|
osteoporosis
|
[NCBI]
|
1.36433e-05
|
|
|
STAT3
|
[NCBI]
|
1.3557e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.35549e-05
|
|
|
TG
|
[NCBI]
|
1.35282e-05
|
|
|
PRSS1
|
[NCBI]
|
1.35144e-05
|
|
|
COL17A1
|
[NCBI]
|
1.35144e-05
|
|
|
XDH
|
[NCBI]
|
1.33809e-05
|
|
|
LS
|
[NCBI]
|
1.32239e-05
|
|
|
ERMAP
|
[NCBI]
|
1.31734e-05
|
|
|
TREH
|
[NCBI]
|
1.31734e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
1.31734e-05
|
|
|
PRDX3
|
[NCBI]
|
1.31734e-05
|
|
|
IL10RA
|
[NCBI]
|
1.31734e-05
|
|
|
NUDT3
|
[NCBI]
|
1.31734e-05
|
|
|
INTS6
|
[NCBI]
|
1.31734e-05
|
|
|
ICAP1
|
[NCBI]
|
1.31734e-05
|
|
|
PRKCSH
|
[NCBI]
|
1.31734e-05
|
|
|
EPN1
|
[NCBI]
|
1.31734e-05
|
|
|
HYAL1
|
[NCBI]
|
1.31734e-05
|
|
|
CSTA
|
[NCBI]
|
1.31734e-05
|
|
|
EIF5B
|
[NCBI]
|
1.31734e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.31734e-05
|
|
|
saitohin
|
[NCBI]
|
1.31734e-05
|
|
|
SLC6A5
|
[NCBI]
|
1.31734e-05
|
|
|
GPR56
|
[NCBI]
|
1.31734e-05
|
|
|
PIK3R2
|
[NCBI]
|
1.31734e-05
|
|
|
PHF6
|
[NCBI]
|
1.31734e-05
|
|
|
EVC
|
[NCBI]
|
1.31734e-05
|
|
|
mas20p, s. cerevisiae, homolog of
|
[NCBI]
|
1.31734e-05
|
|
|
huntingtin-interacting protein 12
|
[NCBI]
|
1.31734e-05
|
|
|
KNSL2
|
[NCBI]
|
1.31734e-05
|
|
|
CSNK1E
|
[NCBI]
|
1.31734e-05
|
|
|
PIP5K1B
|
[NCBI]
|
1.31734e-05
|
|
|
PTGES3
|
[NCBI]
|
1.31734e-05
|
|
|
VAPB
|
[NCBI]
|
1.31734e-05
|
|
|
GPR14
|
[NCBI]
|
1.31734e-05
|
|
|
SLC26A5
|
[NCBI]
|
1.31734e-05
|
|
|
FBP1
|
[NCBI]
|
1.31734e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
1.31734e-05
|
|
|
IRAK3
|
[NCBI]
|
1.31734e-05
|
|
|
PLD2
|
[NCBI]
|
1.31663e-05
|
|
|
thiourea tasting
|
[NCBI]
|
1.30091e-05
|
|
|
PBD
|
[NCBI]
|
1.30091e-05
|
|
|
PNKD1
|
[NCBI]
|
1.30091e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
1.30091e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.30091e-05
|
|
|
ODDD
|
[NCBI]
|
1.30091e-05
|
|
|
MHA
|
[NCBI]
|
1.30091e-05
|
|
|
NEM3
|
[NCBI]
|
1.30091e-05
|
|
|
PKD1
|
[NCBI]
|
1.28869e-05
|
|
|
IRS2
|
[NCBI]
|
1.28315e-05
|
|
|
GCDH
|
[NCBI]
|
1.28315e-05
|
|
|
CST3
|
[NCBI]
|
1.28315e-05
|
|
|
PRODH
|
[NCBI]
|
1.28315e-05
|
|
|
TSC2
|
[NCBI]
|
1.27637e-05
|
|
|
ALPL
|
[NCBI]
|
1.25091e-05
|
|
|
SLC40A1
|
[NCBI]
|
1.25091e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
1.24083e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
1.24083e-05
|
|
|
lung cancer
|
[NCBI]
|
1.24083e-05
|
|
|
HNFJ
|
[NCBI]
|
1.24083e-05
|
|
|
ARSA
|
[NCBI]
|
1.22064e-05
|
|
|
ENPP1
|
[NCBI]
|
1.21984e-05
|
|
|
KRT5
|
[NCBI]
|
1.21984e-05
|
|
|
MTND6
|
[NCBI]
|
1.21984e-05
|
|
|
von willebrand disease
|
[NCBI]
|
1.2077e-05
|
|
|
GDA
|
[NCBI]
|
1.2031e-05
|
|
|
KIF5A
|
[NCBI]
|
1.2031e-05
|
|
|
ABCB7
|
[NCBI]
|
1.2031e-05
|
|
|
PSCD3
|
[NCBI]
|
1.2031e-05
|
|
|
HSD17B3
|
[NCBI]
|
1.2031e-05
|
|
|
PLK2
|
[NCBI]
|
1.2031e-05
|
|
|
GPRK6
|
[NCBI]
|
1.2031e-05
|
|
|
MYL3
|
[NCBI]
|
1.2031e-05
|
|
|
NMBR
|
[NCBI]
|
1.2031e-05
|
|
|
humanin
|
[NCBI]
|
1.2031e-05
|
|
|
SRI
|
[NCBI]
|
1.2031e-05
|
|
|
CFC1
|
[NCBI]
|
1.2031e-05
|
|
|
SLC4A11
|
[NCBI]
|
1.2031e-05
|
|
|
RFXANK
|
[NCBI]
|
1.2031e-05
|
|
|
COX10
|
[NCBI]
|
1.2031e-05
|
|
|
HMCN1
|
[NCBI]
|
1.2031e-05
|
|
|
COTL1
|
[NCBI]
|
1.2031e-05
|
|
|
MTTH
|
[NCBI]
|
1.2031e-05
|
|
|
PVRL2
|
[NCBI]
|
1.2031e-05
|
|
|
LAIR1
|
[NCBI]
|
1.2031e-05
|
|
|
MTTF
|
[NCBI]
|
1.2031e-05
|
|
|
SESN1
|
[NCBI]
|
1.2031e-05
|
|
|
KCNE2
|
[NCBI]
|
1.2031e-05
|
|
|
KCNAB2
|
[NCBI]
|
1.2031e-05
|
|
|
CRMP1
|
[NCBI]
|
1.2031e-05
|
|
|
DLG5
|
[NCBI]
|
1.2031e-05
|
|
|
ANK2
|
[NCBI]
|
1.2031e-05
|
|
|
PSCD1
|
[NCBI]
|
1.2031e-05
|
|
|
COL19A1
|
[NCBI]
|
1.2031e-05
|
|
|
FBXL3
|
[NCBI]
|
1.2031e-05
|
|
|
PARK2
|
[NCBI]
|
1.2027e-05
|
|
|
POU1F1
|
[NCBI]
|
1.18985e-05
|
|
|
APOA1
|
[NCBI]
|
1.18506e-05
|
|
|
RCDP1
|
[NCBI]
|
1.18384e-05
|
|
|
OKS
|
[NCBI]
|
1.18384e-05
|
|
|
OPTB1
|
[NCBI]
|
1.18384e-05
|
|
|
DFNB1
|
[NCBI]
|
1.18384e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
1.18384e-05
|
|
|
PPOX
|
[NCBI]
|
1.1609e-05
|
|
|
MTTK
|
[NCBI]
|
1.1609e-05
|
|
|
QTRT1
|
[NCBI]
|
1.1609e-05
|
|
|
MAS
|
[NCBI]
|
1.14585e-05
|
|
|
HP
|
[NCBI]
|
1.13909e-05
|
|
|
SLAMF1
|
[NCBI]
|
1.13292e-05
|
|
|
IL13
|
[NCBI]
|
1.13292e-05
|
|
|
GHRL
|
[NCBI]
|
1.13292e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.1297e-05
|
|
|
neural tube defects
|
[NCBI]
|
1.1297e-05
|
|
|
AR
|
[NCBI]
|
1.12399e-05
|
|
|
IL13RA1
|
[NCBI]
|
1.10903e-05
|
|
|
PRKAG1
|
[NCBI]
|
1.10903e-05
|
|
|
SLURP1
|
[NCBI]
|
1.10903e-05
|
|
|
MFN1
|
[NCBI]
|
1.10903e-05
|
|
|
RYK
|
[NCBI]
|
1.10903e-05
|
|
|
FBLN5
|
[NCBI]
|
1.10903e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.10903e-05
|
|
|
KLF11
|
[NCBI]
|
1.10903e-05
|
|
|
TLR10
|
[NCBI]
|
1.10903e-05
|
|
|
AKAP13
|
[NCBI]
|
1.10903e-05
|
|
|
WNT2
|
[NCBI]
|
1.10903e-05
|
|
|
ACTN4
|
[NCBI]
|
1.10903e-05
|
|
|
PLCE1
|
[NCBI]
|
1.10903e-05
|
|
|
CAMK4
|
[NCBI]
|
1.10903e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
1.10903e-05
|
|
|
GCLC
|
[NCBI]
|
1.10903e-05
|
|
|
PCAF
|
[NCBI]
|
1.10903e-05
|
|
|
WISP3
|
[NCBI]
|
1.10903e-05
|
|
|
SUMO4
|
[NCBI]
|
1.10903e-05
|
|
|
CIB1
|
[NCBI]
|
1.10903e-05
|
|
|
KCNA5
|
[NCBI]
|
1.10903e-05
|
|
|
CLN8
|
[NCBI]
|
1.10903e-05
|
|
|
TAP2
|
[NCBI]
|
1.10903e-05
|
|
|
ABCC6
|
[NCBI]
|
1.10586e-05
|
|
|
RPS6KA3
|
[NCBI]
|
1.10586e-05
|
|
|
MYO7A
|
[NCBI]
|
1.10586e-05
|
|
|
PTHR1
|
[NCBI]
|
1.10586e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.1012e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
1.07822e-05
|
|
|
apert syndrome
|
[NCBI]
|
1.07822e-05
|
|
|
STGD1
|
[NCBI]
|
1.07822e-05
|
|
|
RP1
|
[NCBI]
|
1.07822e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.07822e-05
|
|
|
testicular tumors
|
[NCBI]
|
1.07822e-05
|
|
|
FANCC
|
[NCBI]
|
1.05431e-05
|
|
|
RUNX2
|
[NCBI]
|
1.05431e-05
|
|
|
CHEK2
|
[NCBI]
|
1.05431e-05
|
|
|
OPTN
|
[NCBI]
|
1.05431e-05
|
|
|
ZS
|
[NCBI]
|
1.03973e-05
|
|
|
APS1
|
[NCBI]
|
1.03973e-05
|
|
|
VHL
|
[NCBI]
|
1.03888e-05
|
|
|
NOD2
|
[NCBI]
|
1.02972e-05
|
|
|
PKLR
|
[NCBI]
|
1.02972e-05
|
|
|
NR0B1
|
[NCBI]
|
1.02972e-05
|
|
|
RPL4
|
[NCBI]
|
1.0293e-05
|
|
|
HIST2H2AA
|
[NCBI]
|
1.0293e-05
|
|
|
SNCB
|
[NCBI]
|
1.0293e-05
|
|
|
TTK
|
[NCBI]
|
1.0293e-05
|
|
|
HLXB9
|
[NCBI]
|
1.0293e-05
|
|
|
COLQ
|
[NCBI]
|
1.0293e-05
|
|
|
FKBP1B
|
[NCBI]
|
1.0293e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.0293e-05
|
|
|
ISL1
|
[NCBI]
|
1.0293e-05
|
|
|
GNB2L1
|
[NCBI]
|
1.0293e-05
|
|
|
GOPC
|
[NCBI]
|
1.0293e-05
|
|
|
TMC1
|
[NCBI]
|
1.0293e-05
|
|
|
COL9A3
|
[NCBI]
|
1.0293e-05
|
|
|
RENT1
|
[NCBI]
|
1.0293e-05
|
|
|
SEPN1
|
[NCBI]
|
1.0293e-05
|
|
|
F2RL2
|
[NCBI]
|
1.0293e-05
|
|
|
POFUT1
|
[NCBI]
|
1.0293e-05
|
|
|
PRPF31
|
[NCBI]
|
1.0293e-05
|
|
|
CLDN14
|
[NCBI]
|
1.0293e-05
|
|
|
GABRD
|
[NCBI]
|
1.0293e-05
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
1.0293e-05
|
|
|
FANCE
|
[NCBI]
|
1.0293e-05
|
|
|
CYP4A11
|
[NCBI]
|
1.0293e-05
|
|
|
EVC2
|
[NCBI]
|
1.0293e-05
|
|
|
SLC22A4
|
[NCBI]
|
1.0293e-05
|
|
|
AURKC
|
[NCBI]
|
1.0293e-05
|
|
|
DKC
|
[NCBI]
|
1.02921e-05
|
|
|
STL1
|
[NCBI]
|
1.02921e-05
|
|
|
fabry disease
|
[NCBI]
|
1.01453e-05
|
|
|
APOE
|
[NCBI]
|
1.01179e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.00589e-05
|
|
|
GHR
|
[NCBI]
|
1.00489e-05
|
|
|
LAT
|
[NCBI]
|
9.94663e-06
|
|
|
LIFR
|
[NCBI]
|
9.82756e-06
|
|
|
BCPM
|
[NCBI]
|
9.82498e-06
|
|
|
GBA
|
[NCBI]
|
9.80378e-06
|
|
|
RASA1
|
[NCBI]
|
9.64104e-06
|
|
|
ARF6
|
[NCBI]
|
9.60302e-06
|
|
|
ABCA4
|
[NCBI]
|
9.60302e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
9.60302e-06
|
|
|
FGF19
|
[NCBI]
|
9.60287e-06
|
|
|
FGF14
|
[NCBI]
|
9.60287e-06
|
|
|
HSPA8
|
[NCBI]
|
9.60287e-06
|
|
|
SACS
|
[NCBI]
|
9.60287e-06
|
|
|
POR
|
[NCBI]
|
9.60287e-06
|
|
|
TLN1
|
[NCBI]
|
9.60287e-06
|
|
|
GZMK
|
[NCBI]
|
9.60287e-06
|
|
|
CUL4A
|
[NCBI]
|
9.60287e-06
|
|
|
TDGF1
|
[NCBI]
|
9.60287e-06
|
|
|
CASP10
|
[NCBI]
|
9.60287e-06
|
|
|
MAF
|
[NCBI]
|
9.60287e-06
|
|
|
ARSE
|
[NCBI]
|
9.60287e-06
|
|
|
MTRR
|
[NCBI]
|
9.60287e-06
|
|
|
ANXA6
|
[NCBI]
|
9.60287e-06
|
|
|
MKKS
|
[NCBI]
|
9.60287e-06
|
|
|
TEK
|
[NCBI]
|
9.60287e-06
|
|
|
hemojuvelin
|
[NCBI]
|
9.60287e-06
|
|
|
KCNA4
|
[NCBI]
|
9.60287e-06
|
|
|
MYLK
|
[NCBI]
|
9.60287e-06
|
|
|
GSTZ1
|
[NCBI]
|
9.60287e-06
|
|
|
CASQ2
|
[NCBI]
|
9.60287e-06
|
|
|
FHL1
|
[NCBI]
|
9.60287e-06
|
|
|
COL2A1
|
[NCBI]
|
9.52457e-06
|
|
|
CD
|
[NCBI]
|
9.41906e-06
|
|
|
SLOS
|
[NCBI]
|
9.40373e-06
|
|
|
GLA
|
[NCBI]
|
9.38492e-06
|
|
|
gastric cancer
|
[NCBI]
|
9.37944e-06
|
|
|
SHBG
|
[NCBI]
|
9.28868e-06
|
|
|
GCK
|
[NCBI]
|
9.2537e-06
|
|
|
SOX9
|
[NCBI]
|
9.17297e-06
|
|
|
ENG
|
[NCBI]
|
9.17297e-06
|
|
|
FA
|
[NCBI]
|
9.08329e-06
|
|
|
TRPC6
|
[NCBI]
|
8.99597e-06
|
|
|
TRPS1
|
[NCBI]
|
8.99597e-06
|
|
|
HPD
|
[NCBI]
|
8.99597e-06
|
|
|
ARF3
|
[NCBI]
|
8.99597e-06
|
|
|
ERN1
|
[NCBI]
|
8.99597e-06
|
|
|
ZFPM2
|
[NCBI]
|
8.99597e-06
|
|
|
ERBB3
|
[NCBI]
|
8.99597e-06
|
|
|
CD28
|
[NCBI]
|
8.99597e-06
|
|
|
GUCA1A
|
[NCBI]
|
8.99597e-06
|
|
|
SCN1B
|
[NCBI]
|
8.99597e-06
|
|
|
MAP2K2
|
[NCBI]
|
8.99597e-06
|
|
|
APOA5
|
[NCBI]
|
8.99597e-06
|
|
|
EPHX2
|
[NCBI]
|
8.99597e-06
|
|
|
PHYH
|
[NCBI]
|
8.99597e-06
|
|
|
SETX
|
[NCBI]
|
8.99597e-06
|
|
|
SLC4A4
|
[NCBI]
|
8.99597e-06
|
|
|
EDAR
|
[NCBI]
|
8.99597e-06
|
|
|
CLDN16
|
[NCBI]
|
8.99597e-06
|
|
|
FGF5
|
[NCBI]
|
8.99597e-06
|
|
|
DIO1
|
[NCBI]
|
8.99597e-06
|
|
|
CNGB3
|
[NCBI]
|
8.99597e-06
|
|
|
AKT2
|
[NCBI]
|
8.99597e-06
|
|
|
LITAF
|
[NCBI]
|
8.99597e-06
|
|
|
ICSBP1
|
[NCBI]
|
8.99597e-06
|
|
|
AMT
|
[NCBI]
|
8.99597e-06
|
|
|
MYCBP2
|
[NCBI]
|
8.99597e-06
|
|
|
KRT2A
|
[NCBI]
|
8.99597e-06
|
|
|
ADRBK1
|
[NCBI]
|
8.99597e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
8.99597e-06
|
|
|
RAC2
|
[NCBI]
|
8.99597e-06
|
|
|
LMAN1
|
[NCBI]
|
8.99597e-06
|
|
|
SPG3A
|
[NCBI]
|
8.95411e-06
|
|
|
PARK2
|
[NCBI]
|
8.95411e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
8.95411e-06
|
|
|
PGL1
|
[NCBI]
|
8.95411e-06
|
|
|
FPGS
|
[NCBI]
|
8.73565e-06
|
|
|
ABCA1
|
[NCBI]
|
8.57141e-06
|
|
|
ERBB2
|
[NCBI]
|
8.57141e-06
|
|
|
TNFRSF6
|
[NCBI]
|
8.57141e-06
|
|
|
CTSC
|
[NCBI]
|
8.57141e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
8.54777e-06
|
|
|
SPG4
|
[NCBI]
|
8.54777e-06
|
|
|
SECISBP2
|
[NCBI]
|
8.45554e-06
|
|
|
SLC17A5
|
[NCBI]
|
8.45554e-06
|
|
|
ITCH
|
[NCBI]
|
8.45554e-06
|
|
|
GP9
|
[NCBI]
|
8.45554e-06
|
|
|
FACL4
|
[NCBI]
|
8.45554e-06
|
|
|
EIF5
|
[NCBI]
|
8.45554e-06
|
|
|
HSD17B10
|
[NCBI]
|
8.45554e-06
|
|
|
ACO2
|
[NCBI]
|
8.45554e-06
|
|
|
LRP6
|
[NCBI]
|
8.45554e-06
|
|
|
INHA
|
[NCBI]
|
8.45554e-06
|
|
|
PRND
|
[NCBI]
|
8.45554e-06
|
|
|
MFNG
|
[NCBI]
|
8.45554e-06
|
|
|
INSIG2
|
[NCBI]
|
8.45554e-06
|
|
|
T
|
[NCBI]
|
8.45554e-06
|
|
|
SEMA3B
|
[NCBI]
|
8.45554e-06
|
|
|
INSIG1
|
[NCBI]
|
8.45554e-06
|
|
|
NAGS
|
[NCBI]
|
8.45554e-06
|
|
|
CFD
|
[NCBI]
|
8.45554e-06
|
|
|
NR2E3
|
[NCBI]
|
8.45554e-06
|
|
|
GATA2
|
[NCBI]
|
8.45554e-06
|
|
|
TIMP2
|
[NCBI]
|
8.45554e-06
|
|
|
MTTI
|
[NCBI]
|
8.45554e-06
|
|
|
PEX1
|
[NCBI]
|
8.45554e-06
|
|
|
RBBP8
|
[NCBI]
|
8.45554e-06
|
|
|
CBFB
|
[NCBI]
|
8.45554e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.33698e-06
|
|
|
GHRH
|
[NCBI]
|
8.25334e-06
|
|
|
PRF1
|
[NCBI]
|
8.1966e-06
|
|
|
FGF23
|
[NCBI]
|
8.1966e-06
|
|
|
FCAS
|
[NCBI]
|
8.15929e-06
|
|
|
CDPX2
|
[NCBI]
|
8.15929e-06
|
|
|
meningioma, familial
|
[NCBI]
|
8.15929e-06
|
|
|
OCA2
|
[NCBI]
|
8.15929e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
8.01643e-06
|
|
|
MLC1
|
[NCBI]
|
7.96945e-06
|
|
|
BRIP1
|
[NCBI]
|
7.96945e-06
|
|
|
NLRP3
|
[NCBI]
|
7.96945e-06
|
|
|
MCPH1
|
[NCBI]
|
7.96945e-06
|
|
|
SLC6A2
|
[NCBI]
|
7.96945e-06
|
|
|
RDH5
|
[NCBI]
|
7.96945e-06
|
|
|
POLB
|
[NCBI]
|
7.96945e-06
|
|
|
ZIC3
|
[NCBI]
|
7.96945e-06
|
|
|
DGAT1
|
[NCBI]
|
7.96945e-06
|
|
|
NOX1
|
[NCBI]
|
7.96945e-06
|
|
|
SLC7A9
|
[NCBI]
|
7.96945e-06
|
|
|
COL4A4
|
[NCBI]
|
7.96945e-06
|
|
|
PAG1
|
[NCBI]
|
7.96945e-06
|
|
|
CX3CR1
|
[NCBI]
|
7.96945e-06
|
|
|
PAX9
|
[NCBI]
|
7.96945e-06
|
|
|
ITPA
|
[NCBI]
|
7.96945e-06
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
7.96945e-06
|
|
|
RANBP1
|
[NCBI]
|
7.96945e-06
|
|
|
C10ORF2
|
[NCBI]
|
7.96945e-06
|
|
|
NEDD9
|
[NCBI]
|
7.96945e-06
|
|
|
MERTK
|
[NCBI]
|
7.96945e-06
|
|
|
TIMELESS
|
[NCBI]
|
7.96945e-06
|
|
|
TIMM8A
|
[NCBI]
|
7.96945e-06
|
|
|
PON2
|
[NCBI]
|
7.96945e-06
|
|
|
BFSP2
|
[NCBI]
|
7.96945e-06
|
|
|
FRAP1
|
[NCBI]
|
7.95956e-06
|
|
|
DHFR
|
[NCBI]
|
7.91741e-06
|
|
|
VHL
|
[NCBI]
|
7.8859e-06
|
|
|
BRCA1
|
[NCBI]
|
7.85863e-06
|
|
|
CMTX1
|
[NCBI]
|
7.78766e-06
|
|
|
MEB
|
[NCBI]
|
7.78766e-06
|
|
|
SCZD
|
[NCBI]
|
7.68394e-06
|
|
|
F13A1
|
[NCBI]
|
7.66967e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
7.5286e-06
|
|
|
MATN3
|
[NCBI]
|
7.5286e-06
|
|
|
FCGR2B
|
[NCBI]
|
7.5286e-06
|
|
|
EIF2S1
|
[NCBI]
|
7.5286e-06
|
|
|
SIX1
|
[NCBI]
|
7.5286e-06
|
|
|
KRT8
|
[NCBI]
|
7.5286e-06
|
|
|
GNAQ
|
[NCBI]
|
7.5286e-06
|
|
|
G22P1
|
[NCBI]
|
7.5286e-06
|
|
|
CTBP1
|
[NCBI]
|
7.5286e-06
|
|
|
DYRK1A
|
[NCBI]
|
7.5286e-06
|
|
|
COL6A3
|
[NCBI]
|
7.5286e-06
|
|
|
ICOS
|
[NCBI]
|
7.5286e-06
|
|
|
PRDX5
|
[NCBI]
|
7.5286e-06
|
|
|
CNTFR
|
[NCBI]
|
7.5286e-06
|
|
|
ICAM5
|
[NCBI]
|
7.5286e-06
|
|
|
UNG
|
[NCBI]
|
7.50273e-06
|
|
|
AGT
|
[NCBI]
|
7.50273e-06
|
|
|
LFS1
|
[NCBI]
|
7.43193e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
7.43193e-06
|
|
|
CDG1A
|
[NCBI]
|
7.43193e-06
|
|
|
CVID
|
[NCBI]
|
7.30337e-06
|
|
|
MED12
|
[NCBI]
|
7.12602e-06
|
|
|
XRCC2
|
[NCBI]
|
7.12602e-06
|
|
|
TCIRG1
|
[NCBI]
|
7.12602e-06
|
|
|
FLNB
|
[NCBI]
|
7.12602e-06
|
|
|
KIF2C
|
[NCBI]
|
7.12602e-06
|
|
|
ITGA2
|
[NCBI]
|
7.12602e-06
|
|
|
LDLRAP1
|
[NCBI]
|
7.12602e-06
|
|
|
CSF2RB
|
[NCBI]
|
7.12602e-06
|
|
|
GABRA1
|
[NCBI]
|
7.12602e-06
|
|
|
SFTPA1
|
[NCBI]
|
7.12602e-06
|
|
|
MSR1
|
[NCBI]
|
7.12602e-06
|
|
|
PVRL1
|
[NCBI]
|
7.12602e-06
|
|
|
IKBKAP
|
[NCBI]
|
7.12602e-06
|
|
|
MTHFD1
|
[NCBI]
|
7.12602e-06
|
|
|
HLCS
|
[NCBI]
|
7.12602e-06
|
|
|
ATP1A1
|
[NCBI]
|
7.12602e-06
|
|
|
CALCR
|
[NCBI]
|
7.12602e-06
|
|
|
NCL
|
[NCBI]
|
7.12602e-06
|
|
|
NQO1
|
[NCBI]
|
7.12602e-06
|
|
|
NPAS2
|
[NCBI]
|
7.12602e-06
|
|
|
CDK5R1
|
[NCBI]
|
7.12602e-06
|
|
|
UBB
|
[NCBI]
|
7.12602e-06
|
|
|
TPM1
|
[NCBI]
|
7.12602e-06
|
|
|
ABCB4
|
[NCBI]
|
7.12602e-06
|
|
|
WNK4
|
[NCBI]
|
7.12602e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.09126e-06
|
|
|
PDS
|
[NCBI]
|
7.09126e-06
|
|
|
CTNS
|
[NCBI]
|
7.09126e-06
|
|
|
ADA
|
[NCBI]
|
7.04837e-06
|
|
|
TPO
|
[NCBI]
|
6.89784e-06
|
|
|
HHF1
|
[NCBI]
|
6.76485e-06
|
|
|
BTHS
|
[NCBI]
|
6.76485e-06
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
6.76485e-06
|
|
|
TECTA
|
[NCBI]
|
6.75621e-06
|
|
|
PLA2G7
|
[NCBI]
|
6.75621e-06
|
|
|
PCSK9
|
[NCBI]
|
6.75621e-06
|
|
|
DCTN1
|
[NCBI]
|
6.75621e-06
|
|
|
NOTCH3
|
[NCBI]
|
6.75621e-06
|
|
|
AGTR2
|
[NCBI]
|
6.75621e-06
|
|
|
GRB10
|
[NCBI]
|
6.75621e-06
|
|
|
SMARCB1
|
[NCBI]
|
6.75621e-06
|
|
|
RHAG
|
[NCBI]
|
6.75621e-06
|
|
|
CACNA1F
|
[NCBI]
|
6.75621e-06
|
|
|
BTD
|
[NCBI]
|
6.75621e-06
|
|
|
MTMR2
|
[NCBI]
|
6.75621e-06
|
|
|
HABP2
|
[NCBI]
|
6.75621e-06
|
|
|
HBD
|
[NCBI]
|
6.58192e-06
|
|
|
POAG
|
[NCBI]
|
6.45196e-06
|
|
|
ASL
|
[NCBI]
|
6.44072e-06
|
|
|
SLC11A1
|
[NCBI]
|
6.44072e-06
|
|
|
RHOA
|
[NCBI]
|
6.4148e-06
|
|
|
MMP13
|
[NCBI]
|
6.4148e-06
|
|
|
HPSE
|
[NCBI]
|
6.4148e-06
|
|
|
MTND4L
|
[NCBI]
|
6.4148e-06
|
|
|
GPHN
|
[NCBI]
|
6.4148e-06
|
|
|
PDCD1
|
[NCBI]
|
6.4148e-06
|
|
|
PDC
|
[NCBI]
|
6.4148e-06
|
|
|
GGCX
|
[NCBI]
|
6.4148e-06
|
|
|
TULP1
|
[NCBI]
|
6.4148e-06
|
|
|
EPAS1
|
[NCBI]
|
6.4148e-06
|
|
|
ALOX5AP
|
[NCBI]
|
6.4148e-06
|
|
|
CTNS
|
[NCBI]
|
6.4148e-06
|
|
|
RAB27A
|
[NCBI]
|
6.4148e-06
|
|
|
AGL
|
[NCBI]
|
6.4148e-06
|
|
|
CRB1
|
[NCBI]
|
6.4148e-06
|
|
|
GALE
|
[NCBI]
|
6.4148e-06
|
|
|
SGSH
|
[NCBI]
|
6.4148e-06
|
|
|
ANP32A
|
[NCBI]
|
6.4148e-06
|
|
|
SSTR5
|
[NCBI]
|
6.4148e-06
|
|
|
MOS
|
[NCBI]
|
6.4148e-06
|
|
|
PGK2
|
[NCBI]
|
6.4148e-06
|
|
|
FOXP2
|
[NCBI]
|
6.4148e-06
|
|
|
ACTB
|
[NCBI]
|
6.4148e-06
|
|
|
SDHB
|
[NCBI]
|
6.4148e-06
|
|
|
CERK
|
[NCBI]
|
6.4148e-06
|
|
|
MBL2
|
[NCBI]
|
6.3361e-06
|
|
|
MTND4
|
[NCBI]
|
6.30272e-06
|
|
|
PPIA
|
[NCBI]
|
6.26599e-06
|
|
|
ATM
|
[NCBI]
|
6.26599e-06
|
|
|
UGDH
|
[NCBI]
|
6.09824e-06
|
|
|
MAZ
|
[NCBI]
|
6.09824e-06
|
|
|
ADRB1
|
[NCBI]
|
6.09824e-06
|
|
|
CAMK2A
|
[NCBI]
|
6.09824e-06
|
|
|
PCSK1
|
[NCBI]
|
6.09824e-06
|
|
|
CYP2C9
|
[NCBI]
|
6.09824e-06
|
|
|
LEF1
|
[NCBI]
|
6.09824e-06
|
|
|
RAN
|
[NCBI]
|
6.09824e-06
|
|
|
GJD2
|
[NCBI]
|
6.09824e-06
|
|
|
COL5A1
|
[NCBI]
|
6.09824e-06
|
|
|
ALOX5
|
[NCBI]
|
6.09824e-06
|
|
|
SCN9A
|
[NCBI]
|
6.09824e-06
|
|
|
TPH1
|
[NCBI]
|
6.09824e-06
|
|
|
PMCH
|
[NCBI]
|
6.01037e-06
|
|
|
ALD
|
[NCBI]
|
5.9352e-06
|
|
|
TSD
|
[NCBI]
|
5.89276e-06
|
|
|
HSAN3
|
[NCBI]
|
5.8641e-06
|
|
|
HAE
|
[NCBI]
|
5.8641e-06
|
|
|
MYO6
|
[NCBI]
|
5.80358e-06
|
|
|
CBFA2T1
|
[NCBI]
|
5.80358e-06
|
|
|
RNASEL
|
[NCBI]
|
5.80358e-06
|
|
|
ROR2
|
[NCBI]
|
5.80358e-06
|
|
|
IL7R
|
[NCBI]
|
5.80358e-06
|
|
|
TAZ
|
[NCBI]
|
5.80358e-06
|
|
|
CYP11A1
|
[NCBI]
|
5.80358e-06
|
|
|
MYOD1
|
[NCBI]
|
5.80358e-06
|
|
|
GJA4
|
[NCBI]
|
5.80358e-06
|
|
|
TGFB1
|
[NCBI]
|
5.65729e-06
|
|
|
LI1
|
[NCBI]
|
5.58792e-06
|
|
|
CBL
|
[NCBI]
|
5.5284e-06
|
|
|
F2RL1
|
[NCBI]
|
5.5284e-06
|
|
|
DEFA1
|
[NCBI]
|
5.5284e-06
|
|
|
SURF1
|
[NCBI]
|
5.5284e-06
|
|
|
SPHK1
|
[NCBI]
|
5.5284e-06
|
|
|
NEFL
|
[NCBI]
|
5.5284e-06
|
|
|
IL6R
|
[NCBI]
|
5.5284e-06
|
|
|
IL6ST
|
[NCBI]
|
5.5284e-06
|
|
|
FOXC1
|
[NCBI]
|
5.5284e-06
|
|
|
GJA3
|
[NCBI]
|
5.5284e-06
|
|
|
CBP
|
[NCBI]
|
5.5284e-06
|
|
|
VCAM1
|
[NCBI]
|
5.5284e-06
|
|
|
HSD17B4
|
[NCBI]
|
5.5284e-06
|
|
|
SPG7
|
[NCBI]
|
5.5284e-06
|
|
|
PTS
|
[NCBI]
|
5.5284e-06
|
|
|
TRHR
|
[NCBI]
|
5.5284e-06
|
|
|
GLDC
|
[NCBI]
|
5.5284e-06
|
|
|
USH1C
|
[NCBI]
|
5.5284e-06
|
|
|
TSHB
|
[NCBI]
|
5.5284e-06
|
|
|
SLC6A3
|
[NCBI]
|
5.50361e-06
|
|
|
RPS6KA1
|
[NCBI]
|
5.27064e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
5.27064e-06
|
|
|
ERCC3
|
[NCBI]
|
5.27064e-06
|
|
|
MUTYH
|
[NCBI]
|
5.27064e-06
|
|
|
PER2
|
[NCBI]
|
5.27064e-06
|
|
|
XRCC9
|
[NCBI]
|
5.27064e-06
|
|
|
ADRB3
|
[NCBI]
|
5.27064e-06
|
|
|
SGCE
|
[NCBI]
|
5.27064e-06
|
|
|
PGM3
|
[NCBI]
|
5.27064e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
5.27064e-06
|
|
|
DNM1L
|
[NCBI]
|
5.27064e-06
|
|
|
FLT4
|
[NCBI]
|
5.27064e-06
|
|
|
PCCB
|
[NCBI]
|
5.27064e-06
|
|
|
SLC6A8
|
[NCBI]
|
5.27064e-06
|
|
|
ECM1
|
[NCBI]
|
5.27064e-06
|
|
|
TP53
|
[NCBI]
|
5.13262e-06
|
|
|
BRCA2
|
[NCBI]
|
5.09627e-06
|
|
|
DYT1
|
[NCBI]
|
5.06836e-06
|
|
|
ALGS1
|
[NCBI]
|
5.06836e-06
|
|
|
SN
|
[NCBI]
|
5.02856e-06
|
|
|
GALK1
|
[NCBI]
|
5.02856e-06
|
|
|
PHOX2B
|
[NCBI]
|
5.02856e-06
|
|
|
TMOD
|
[NCBI]
|
5.02856e-06
|
|
|
SFTPB
|
[NCBI]
|
5.02856e-06
|
|
|
CYP2C19
|
[NCBI]
|
5.02856e-06
|
|
|
C9
|
[NCBI]
|
5.02856e-06
|
|
|
NEB
|
[NCBI]
|
5.02856e-06
|
|
|
DMBT1
|
[NCBI]
|
5.02856e-06
|
|
|
BMP1
|
[NCBI]
|
5.02856e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
5.02856e-06
|
|
|
AHR
|
[NCBI]
|
4.98321e-06
|
|
|
H6PD
|
[NCBI]
|
4.96971e-06
|
|
|
MC4R
|
[NCBI]
|
4.96971e-06
|
|
|
GPI
|
[NCBI]
|
4.89498e-06
|
|
|
APOB
|
[NCBI]
|
4.84682e-06
|
|
|
PF4
|
[NCBI]
|
4.8325e-06
|
|
|
EIF4G1
|
[NCBI]
|
4.80067e-06
|
|
|
EPHB2
|
[NCBI]
|
4.80067e-06
|
|
|
PTGS1
|
[NCBI]
|
4.80067e-06
|
|
|
HSPCA
|
[NCBI]
|
4.80067e-06
|
|
|
ABCC3
|
[NCBI]
|
4.80067e-06
|
|
|
CLN3
|
[NCBI]
|
4.80067e-06
|
|
|
CPT2
|
[NCBI]
|
4.80067e-06
|
|
|
FLT3
|
[NCBI]
|
4.80067e-06
|
|
|
CR1
|
[NCBI]
|
4.80067e-06
|
|
|
WIPF1
|
[NCBI]
|
4.80067e-06
|
|
|
ITGB1
|
[NCBI]
|
4.80067e-06
|
|
|
PEX7
|
[NCBI]
|
4.80067e-06
|
|
|
PYGM
|
[NCBI]
|
4.80067e-06
|
|
|
TBX5
|
[NCBI]
|
4.80067e-06
|
|
|
MYH6
|
[NCBI]
|
4.80067e-06
|
|
|
PAX6
|
[NCBI]
|
4.65697e-06
|
|
|
CMT1B
|
[NCBI]
|
4.58933e-06
|
|
|
PIK3CA
|
[NCBI]
|
4.58566e-06
|
|
|
TBP
|
[NCBI]
|
4.58566e-06
|
|
|
GHSR
|
[NCBI]
|
4.58566e-06
|
|
|
DBH
|
[NCBI]
|
4.58566e-06
|
|
|
PDGFRA
|
[NCBI]
|
4.58566e-06
|
|
|
IL1RN
|
[NCBI]
|
4.58566e-06
|
|
|
PLOD1
|
[NCBI]
|
4.58566e-06
|
|
|
PLSCR1
|
[NCBI]
|
4.58566e-06
|
|
|
AMPD1
|
[NCBI]
|
4.58566e-06
|
|
|
ASIP
|
[NCBI]
|
4.58566e-06
|
|
|
JUN
|
[NCBI]
|
4.58566e-06
|
|
|
DKC1
|
[NCBI]
|
4.58566e-06
|
|
|
MC2R
|
[NCBI]
|
4.58566e-06
|
|
|
ARNTL
|
[NCBI]
|
4.58566e-06
|
|
|
CYP27B1
|
[NCBI]
|
4.58566e-06
|
|
|
ATP2A2
|
[NCBI]
|
4.58566e-06
|
|
|
MLH1
|
[NCBI]
|
4.55692e-06
|
|
|
UBE3A
|
[NCBI]
|
4.38242e-06
|
|
|
AACT
|
[NCBI]
|
4.38242e-06
|
|
|
HSPA1A
|
[NCBI]
|
4.38242e-06
|
|
|
NRP1
|
[NCBI]
|
4.38242e-06
|
|
|
NR3C2
|
[NCBI]
|
4.38242e-06
|
|
|
GJB3
|
[NCBI]
|
4.38242e-06
|
|
|
CYP1B1
|
[NCBI]
|
4.38242e-06
|
|
|
WFS1
|
[NCBI]
|
4.38242e-06
|
|
|
CLTC
|
[NCBI]
|
4.38242e-06
|
|
|
HBEGF
|
[NCBI]
|
4.38242e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
4.36393e-06
|
|
|
BRRS
|
[NCBI]
|
4.36393e-06
|
|
|
NR1I2
|
[NCBI]
|
4.35784e-06
|
|
|
PI
|
[NCBI]
|
4.32257e-06
|
|
|
UROS
|
[NCBI]
|
4.18997e-06
|
|
|
MAP2K1
|
[NCBI]
|
4.18997e-06
|
|
|
GFER
|
[NCBI]
|
4.18997e-06
|
|
|
MFN2
|
[NCBI]
|
4.18997e-06
|
|
|
COL4A1
|
[NCBI]
|
4.18997e-06
|
|
|
SLC25A20
|
[NCBI]
|
4.18997e-06
|
|
|
BIRC5
|
[NCBI]
|
4.18997e-06
|
|
|
AGER
|
[NCBI]
|
4.18248e-06
|
|
|
obesity
|
[NCBI]
|
4.14741e-06
|
|
|
ARNT
|
[NCBI]
|
4.0858e-06
|
|
|
ABCC1
|
[NCBI]
|
4.00846e-06
|
|
|
MYO5A
|
[NCBI]
|
4.00745e-06
|
|
|
MMP1
|
[NCBI]
|
4.00745e-06
|
|
|
PIAS1
|
[NCBI]
|
4.00745e-06
|
|
|
SRD5A2
|
[NCBI]
|
4.00745e-06
|
|
|
FGFR4
|
[NCBI]
|
4.00745e-06
|
|
|
KLF6
|
[NCBI]
|
4.00745e-06
|
|
|
TGM1
|
[NCBI]
|
4.00745e-06
|
|
|
HIPK2
|
[NCBI]
|
4.00745e-06
|
|
|
STAT5A
|
[NCBI]
|
3.99198e-06
|
|
|
FCMD
|
[NCBI]
|
3.93941e-06
|
|
|
HHF2
|
[NCBI]
|
3.93941e-06
|
|
|
MTND2
|
[NCBI]
|
3.83409e-06
|
|
|
GLO1
|
[NCBI]
|
3.83409e-06
|
|
|
LYZ
|
[NCBI]
|
3.83409e-06
|
|
|
GALC
|
[NCBI]
|
3.83409e-06
|
|
|
SLN
|
[NCBI]
|
3.83409e-06
|
|
|
CACNA1C
|
[NCBI]
|
3.83409e-06
|
|
|
AMH
|
[NCBI]
|
3.76805e-06
|
|
|
LPL
|
[NCBI]
|
3.69537e-06
|
|
|
GJA5
|
[NCBI]
|
3.6692e-06
|
|
|
CTSK
|
[NCBI]
|
3.6692e-06
|
|
|
TSG101
|
[NCBI]
|
3.6692e-06
|
|
|
PPARGC1A
|
[NCBI]
|
3.6692e-06
|
|
|
LRP8
|
[NCBI]
|
3.6692e-06
|
|
|
IL4R
|
[NCBI]
|
3.6692e-06
|
|
|
EYA1
|
[NCBI]
|
3.6692e-06
|
|
|
HDC
|
[NCBI]
|
3.63245e-06
|
|
|
NF1
|
[NCBI]
|
3.56514e-06
|
|
|
IVD
|
[NCBI]
|
3.51219e-06
|
|
|
MUT
|
[NCBI]
|
3.51219e-06
|
|
|
GJA8
|
[NCBI]
|
3.51219e-06
|
|
|
CD8A
|
[NCBI]
|
3.51219e-06
|
|
|
DYT1
|
[NCBI]
|
3.51219e-06
|
|
|
KL
|
[NCBI]
|
3.51219e-06
|
|
|
PTCH1
|
[NCBI]
|
3.51219e-06
|
|
|
GPX1
|
[NCBI]
|
3.51219e-06
|
|
|
HSCR1
|
[NCBI]
|
3.41474e-06
|
|
|
IKBKB
|
[NCBI]
|
3.36252e-06
|
|
|
BACE1
|
[NCBI]
|
3.36252e-06
|
|
|
SLC22A6
|
[NCBI]
|
3.36252e-06
|
|
|
NOG
|
[NCBI]
|
3.36252e-06
|
|
|
C1NH
|
[NCBI]
|
3.36252e-06
|
|
|
FABP2
|
[NCBI]
|
3.36252e-06
|
|
|
TAF1
|
[NCBI]
|
3.36252e-06
|
|
|
ARX
|
[NCBI]
|
3.36252e-06
|
|
|
SLC25A4
|
[NCBI]
|
3.36252e-06
|
|
|
APEX
|
[NCBI]
|
3.36252e-06
|
|
|
KRT14
|
[NCBI]
|
3.36252e-06
|
|
|
HEXA
|
[NCBI]
|
3.2716e-06
|
|
|
COL1A2
|
[NCBI]
|
3.2716e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
3.2716e-06
|
|
|
ACADM
|
[NCBI]
|
3.24403e-06
|
|
|
CHUK
|
[NCBI]
|
3.21968e-06
|
|
|
TTN
|
[NCBI]
|
3.21968e-06
|
|
|
DDOST
|
[NCBI]
|
3.21968e-06
|
|
|
GP1BA
|
[NCBI]
|
3.21968e-06
|
|
|
XPC
|
[NCBI]
|
3.21968e-06
|
|
|
SOD2
|
[NCBI]
|
3.20779e-06
|
|
|
hurler syndrome
|
[NCBI]
|
3.18613e-06
|
|
|
ADH5
|
[NCBI]
|
3.08325e-06
|
|
|
ACVRL1
|
[NCBI]
|
3.08325e-06
|
|
|
SLBP
|
[NCBI]
|
3.08325e-06
|
|
|
CYP11B2
|
[NCBI]
|
3.08325e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
3.01602e-06
|
|
|
homocystinuria
|
[NCBI]
|
2.98719e-06
|
|
|
AK1
|
[NCBI]
|
2.95282e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
2.95282e-06
|
|
|
IRF3
|
[NCBI]
|
2.95282e-06
|
|
|
CDKN1B
|
[NCBI]
|
2.95282e-06
|
|
|
COL6A1
|
[NCBI]
|
2.95282e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.95282e-06
|
|
|
MEFV
|
[NCBI]
|
2.95282e-06
|
|
|
DCN
|
[NCBI]
|
2.95282e-06
|
|
|
GCH1
|
[NCBI]
|
2.95282e-06
|
|
|
AKR1B1
|
[NCBI]
|
2.94261e-06
|
|
|
OPRM1
|
[NCBI]
|
2.91939e-06
|
|
|
SLC6A4
|
[NCBI]
|
2.87395e-06
|
|
|
COL10A1
|
[NCBI]
|
2.82802e-06
|
|
|
TNFRSF14
|
[NCBI]
|
2.82802e-06
|
|
|
RAC1
|
[NCBI]
|
2.82802e-06
|
|
|
oca2 gene
|
[NCBI]
|
2.82802e-06
|
|
|
RECQL3
|
[NCBI]
|
2.82802e-06
|
|
|
MTND5
|
[NCBI]
|
2.82802e-06
|
|
|
apc gene
|
[NCBI]
|
2.79278e-06
|
|
|
CLCN1
|
[NCBI]
|
2.70853e-06
|
|
|
CYBB
|
[NCBI]
|
2.70853e-06
|
|
|
CFI
|
[NCBI]
|
2.70853e-06
|
|
|
DNAJC5
|
[NCBI]
|
2.70853e-06
|
|
|
ARMD1
|
[NCBI]
|
2.69579e-06
|
|
|
GH1
|
[NCBI]
|
2.59885e-06
|
|
|
RB1
|
[NCBI]
|
2.59746e-06
|
|
|
GLB1
|
[NCBI]
|
2.59404e-06
|
|
|
GSN
|
[NCBI]
|
2.59404e-06
|
|
|
ACCN2
|
[NCBI]
|
2.59404e-06
|
|
|
NBS1
|
[NCBI]
|
2.59404e-06
|
|
|
CBD
|
[NCBI]
|
2.59404e-06
|
|
|
SPG4
|
[NCBI]
|
2.59404e-06
|
|
|
HOS
|
[NCBI]
|
2.54522e-06
|
|
|
ICAM1
|
[NCBI]
|
2.48428e-06
|
|
|
TYRP1
|
[NCBI]
|
2.48428e-06
|
|
|
DAP
|
[NCBI]
|
2.48428e-06
|
|
|
MTCO2
|
[NCBI]
|
2.48428e-06
|
|
|
STAT5B
|
[NCBI]
|
2.48428e-06
|
|
|
CXCR4
|
[NCBI]
|
2.48428e-06
|
|
|
TACR1
|
[NCBI]
|
2.48428e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.48428e-06
|
|
|
SRY
|
[NCBI]
|
2.47881e-06
|
|
|
TYR
|
[NCBI]
|
2.47881e-06
|
|
|
NSF
|
[NCBI]
|
2.47881e-06
|
|
|
NGB
|
[NCBI]
|
2.37898e-06
|
|
|
NDP
|
[NCBI]
|
2.37898e-06
|
|
|
FGF10
|
[NCBI]
|
2.37898e-06
|
|
|
coproporphyria
|
[NCBI]
|
2.37898e-06
|
|
|
BCL6
|
[NCBI]
|
2.37898e-06
|
|
|
GNAS
|
[NCBI]
|
2.36317e-06
|
|
|
GUSB
|
[NCBI]
|
2.30695e-06
|
|
|
ACADS
|
[NCBI]
|
2.27792e-06
|
|
|
FANCA
|
[NCBI]
|
2.27792e-06
|
|
|
ASPA
|
[NCBI]
|
2.27792e-06
|
|
|
MTCO1
|
[NCBI]
|
2.27792e-06
|
|
|
JAK1
|
[NCBI]
|
2.27792e-06
|
|
|
LTA
|
[NCBI]
|
2.27792e-06
|
|
|
GK
|
[NCBI]
|
2.27792e-06
|
|
|
ATP7A
|
[NCBI]
|
2.27792e-06
|
|
|
prostate cancer
|
[NCBI]
|
2.26205e-06
|
|
|
AD
|
[NCBI]
|
2.24707e-06
|
|
|
TYMS
|
[NCBI]
|
2.23413e-06
|
|
|
GRIA2
|
[NCBI]
|
2.18087e-06
|
|
|
wolman disease
|
[NCBI]
|
2.18087e-06
|
|
|
TPI1
|
[NCBI]
|
2.18087e-06
|
|
|
SRC
|
[NCBI]
|
2.14445e-06
|
|
|
IAPP
|
[NCBI]
|
2.09579e-06
|
|
|
CALCRL
|
[NCBI]
|
2.09227e-06
|
|
|
ILK
|
[NCBI]
|
2.08903e-06
|
|
|
SLC1A2
|
[NCBI]
|
2.08764e-06
|
|
|
PPT1
|
[NCBI]
|
2.08764e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.08764e-06
|
|
|
EDNRB
|
[NCBI]
|
2.08764e-06
|
|
|
SVAS
|
[NCBI]
|
2.00154e-06
|
|
|
GNMT
|
[NCBI]
|
1.99804e-06
|
|
|
FY
|
[NCBI]
|
1.99804e-06
|
|
|
PDHA1
|
[NCBI]
|
1.91189e-06
|
|
|
HIF1A
|
[NCBI]
|
1.91189e-06
|
|
|
FXYD1
|
[NCBI]
|
1.91189e-06
|
|
|
CHS
|
[NCBI]
|
1.89888e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
1.87933e-06
|
|
|
CTLA4
|
[NCBI]
|
1.82904e-06
|
|
|
TFR2
|
[NCBI]
|
1.82904e-06
|
|
|
SEMA3A
|
[NCBI]
|
1.82904e-06
|
|
|
COL1A1
|
[NCBI]
|
1.75317e-06
|
|
|
DSTN
|
[NCBI]
|
1.74933e-06
|
|
|
HEXB
|
[NCBI]
|
1.74933e-06
|
|
|
BRAF
|
[NCBI]
|
1.74933e-06
|
|
|
LPA
|
[NCBI]
|
1.74933e-06
|
|
|
GRIA1
|
[NCBI]
|
1.74933e-06
|
|
|
AMACR
|
[NCBI]
|
1.74933e-06
|
|
|
EPOR
|
[NCBI]
|
1.74354e-06
|
|
|
CYP17A1
|
[NCBI]
|
1.67263e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.59881e-06
|
|
|
CMT1A
|
[NCBI]
|
1.54285e-06
|
|
|
UCP2
|
[NCBI]
|
1.53692e-06
|
|
|
ACE
|
[NCBI]
|
1.53379e-06
|
|
|
MTATP6
|
[NCBI]
|
1.52773e-06
|
|
|
VLDLR
|
[NCBI]
|
1.52773e-06
|
|
|
ALK
|
[NCBI]
|
1.51656e-06
|
|
|
CREBBP
|
[NCBI]
|
1.4593e-06
|
|
|
TCF7L2
|
[NCBI]
|
1.4593e-06
|
|
|
TPT1
|
[NCBI]
|
1.4593e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.4593e-06
|
|
|
TSC1
|
[NCBI]
|
1.4593e-06
|
|
|
LCAT
|
[NCBI]
|
1.44938e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.44024e-06
|
|
|
TFPI
|
[NCBI]
|
1.42196e-06
|
|
|
SPINK1
|
[NCBI]
|
1.41672e-06
|
|
|
TLR5
|
[NCBI]
|
1.3934e-06
|
|
|
ADAM17
|
[NCBI]
|
1.3934e-06
|
|
|
CD47
|
[NCBI]
|
1.3934e-06
|
|
|
hypertension, essential
|
[NCBI]
|
1.34215e-06
|
|
|
AANAT
|
[NCBI]
|
1.32992e-06
|
|
|
NTRK1
|
[NCBI]
|
1.32992e-06
|
|
|
MSTN
|
[NCBI]
|
1.32992e-06
|
|
|
SRF
|
[NCBI]
|
1.30829e-06
|
|
|
CDKN2A
|
[NCBI]
|
1.30327e-06
|
|
|
PTK2
|
[NCBI]
|
1.27648e-06
|
|
|
SMAX1
|
[NCBI]
|
1.21718e-06
|
|
|
DAO
|
[NCBI]
|
1.20988e-06
|
|
|
CP
|
[NCBI]
|
1.1561e-06
|
|
|
MTND1
|
[NCBI]
|
1.15314e-06
|
|
|
PSAP
|
[NCBI]
|
1.15314e-06
|
|
|
CDK4
|
[NCBI]
|
1.11017e-06
|
|
|
GALT
|
[NCBI]
|
1.09849e-06
|
|
|
FMR1
|
[NCBI]
|
1.09762e-06
|
|
|
FGFR1
|
[NCBI]
|
1.09541e-06
|
|
|
SLPI
|
[NCBI]
|
1.09541e-06
|
|
|
LHCGR
|
[NCBI]
|
1.04583e-06
|
|
|
PROCR
|
[NCBI]
|
1.04583e-06
|
|
|
INSR
|
[NCBI]
|
1.03145e-06
|
|
|
OTC
|
[NCBI]
|
9.95107e-07
|
|
|
LBR
|
[NCBI]
|
9.46249e-07
|
|
|
A2M
|
[NCBI]
|
9.46249e-07
|
|
|
PARG
|
[NCBI]
|
9.46249e-07
|
|
|
TLR2
|
[NCBI]
|
9.3087e-07
|
|
|
breast cancer
|
[NCBI]
|
9.15287e-07
|
|
|
KLF4
|
[NCBI]
|
8.99191e-07
|
|
|
GNRHR
|
[NCBI]
|
8.99191e-07
|
|
|
DFFB
|
[NCBI]
|
8.99191e-07
|
|
|
F2
|
[NCBI]
|
8.99191e-07
|
|
|
SLC2A2
|
[NCBI]
|
8.53871e-07
|
|
|
hemophilia a
|
[NCBI]
|
8.17873e-07
|
|
|
STAR
|
[NCBI]
|
8.15149e-07
|
|
|
amyloidosis vi
|
[NCBI]
|
8.08655e-07
|
|
|
TNFSF10
|
[NCBI]
|
8.0553e-07
|
|
|
LRP1
|
[NCBI]
|
7.97771e-07
|
|
|
TF
|
[NCBI]
|
7.75416e-07
|
|
|
CDH1
|
[NCBI]
|
7.68221e-07
|
|
|
PGK1
|
[NCBI]
|
7.68221e-07
|
|
|
MMP9
|
[NCBI]
|
7.68221e-07
|
|
|
WT1
|
[NCBI]
|
7.27782e-07
|
|
|
PKD2
|
[NCBI]
|
7.27782e-07
|
|
|
BDNF
|
[NCBI]
|
7.23722e-07
|
|
|
VDR
|
[NCBI]
|
6.90382e-07
|
|
|
NF2
|
[NCBI]
|
6.88867e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
6.88867e-07
|
|
|
PLTP
|
[NCBI]
|
6.54337e-07
|
|
|
GRB2
|
[NCBI]
|
6.51428e-07
|
|
|
HMBS
|
[NCBI]
|
6.5094e-07
|
|
|
ABCB1
|
[NCBI]
|
6.27918e-07
|
|
|
BTC
|
[NCBI]
|
6.1542e-07
|
|
|
EIF4E
|
[NCBI]
|
5.80798e-07
|
|
|
PNMT
|
[NCBI]
|
5.76371e-07
|
|
|
PLK1
|
[NCBI]
|
5.59114e-07
|
|
|
SOCS3
|
[NCBI]
|
5.47523e-07
|
|
|
PTEN
|
[NCBI]
|
5.40917e-07
|
|
|
IL6
|
[NCBI]
|
5.40752e-07
|
|
|
GCCR
|
[NCBI]
|
5.15553e-07
|
|
|
CDC2
|
[NCBI]
|
5.15553e-07
|
|
|
FGF2
|
[NCBI]
|
4.87082e-07
|
|
|
NR5A1
|
[NCBI]
|
4.84852e-07
|
|
|
CTNNB1
|
[NCBI]
|
4.84852e-07
|
|
|
VASP
|
[NCBI]
|
4.69674e-07
|
|
|
BCNS
|
[NCBI]
|
4.58509e-07
|
|
|
REG3A
|
[NCBI]
|
4.55383e-07
|
|
|
CD
|
[NCBI]
|
4.47338e-07
|
|
|
TERT
|
[NCBI]
|
4.4313e-07
|
|
|
AQP2
|
[NCBI]
|
4.27112e-07
|
|
|
MCP
|
[NCBI]
|
4.24974e-07
|
|
|
LAM
|
[NCBI]
|
4.21621e-07
|
|
|
TLR3
|
[NCBI]
|
4.00004e-07
|
|
|
STAT1
|
[NCBI]
|
3.70513e-07
|
|
|
SERPINA6
|
[NCBI]
|
3.68056e-07
|
|
|
NR0B2
|
[NCBI]
|
3.49156e-07
|
|
|
DBI
|
[NCBI]
|
3.24484e-07
|
|
|
FGA
|
[NCBI]
|
3.02598e-07
|
|
|
XIST
|
[NCBI]
|
2.80858e-07
|
|
|
CDK5
|
[NCBI]
|
2.7855e-07
|
|
|
HBG1
|
[NCBI]
|
2.60108e-07
|
|
|
BBS
|
[NCBI]
|
2.58041e-07
|
|
|
BWS
|
[NCBI]
|
2.51268e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
2.47345e-07
|
|
|
MTTL1
|
[NCBI]
|
2.21483e-07
|
|
|
SLC11A2
|
[NCBI]
|
2.21483e-07
|
|
|
ABCG2
|
[NCBI]
|
2.04137e-07
|
|
|
SLC18A3
|
[NCBI]
|
2.04137e-07
|
|
|
IDUA
|
[NCBI]
|
2.0356e-07
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.91814e-07
|
|
|
GAPDH
|
[NCBI]
|
1.88866e-07
|
|
|
MTR
|
[NCBI]
|
1.86533e-07
|
|
|
PNPLA6
|
[NCBI]
|
1.77899e-07
|
|
|
BCR
|
[NCBI]
|
1.26308e-07
|
|
|
HEMB
|
[NCBI]
|
1.22343e-07
|
|
|
SDC2
|
[NCBI]
|
1.19038e-07
|
|
|
MITF
|
[NCBI]
|
1.14114e-07
|
|
|
G6PD
|
[NCBI]
|
1.08699e-07
|
|
|
NMB
|
[NCBI]
|
1.02029e-07
|
|
|
IHH
|
[NCBI]
|
8.99215e-08
|
|
|
TPMT
|
[NCBI]
|
6.31232e-08
|
|
|
WHS
|
[NCBI]
|
5.42956e-08
|
|
|
SMN1
|
[NCBI]
|
5.27041e-08
|
|
|
PLG
|
[NCBI]
|
4.30472e-08
|
|
|
BMP4
|
[NCBI]
|
4.28159e-08
|
|
|
ESR1
|
[NCBI]
|
4.28159e-08
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
4.08645e-08
|
|
|
MEN1
|
[NCBI]
|
3.78471e-08
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
3.78471e-08
|
|
|
RNASE2
|
[NCBI]
|
3.68579e-08
|
|
|
PEDF
|
[NCBI]
|
3.61469e-08
|
|
|
krabbe disease
|
[NCBI]
|
2.77836e-08
|
|
|
GRP
|
[NCBI]
|
2.76199e-08
|
|
|
phenylketonuria
|
[NCBI]
|
2.69421e-08
|
|
|
F3
|
[NCBI]
|
2.61649e-08
|
|
|
RBP1
|
[NCBI]
|
1.7266e-08
|
|
|
LEPR
|
[NCBI]
|
1.58598e-08
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.45763e-08
|
|
|
GIST
|
[NCBI]
|
1.44966e-08
|
|
|
MAOA
|
[NCBI]
|
1.34648e-08
|
|
|
DBA
|
[NCBI]
|
1.02589e-08
|
|
|
MAPK1
|
[NCBI]
|
1.01176e-08
|
|
|
AIRE
|
[NCBI]
|
8.52378e-09
|
|
|
PTGS2
|
[NCBI]
|
8.52378e-09
|
|
|
HDAC1
|
[NCBI]
|
7.23256e-09
|
|
|
PRLR
|
[NCBI]
|
5.72818e-09
|
|
|
IDE
|
[NCBI]
|
1.82572e-09
|
|
|
PIGR
|
[NCBI]
|
1.43344e-09
|
|
|
FAAH
|
[NCBI]
|
1.39539e-09
|
|
|
COMP
|
[NCBI]
|
6.69099e-10
|
|
|
CPB2
|
[NCBI]
|
4.81458e-10
|
|